Brain Small Vessel Disease 1 With Or Without Ocular Anomalies

Mendelian MONDO:0008289 Pathograph 46 Show in embeddings browser COL4A1-related disorder Hereditary cerebral small vessel disease

Brain small vessel disease 1 with or without ocular anomalies (BSVD1) is an autosomal dominant COL4A1 disorder with cerebrovascular involvement ranging from prenatal hemorrhagic injury and porencephaly to adult small-vessel disease or clinically silent MRI abnormalities. Ocular, renal, muscular and other systemic manifestations overlap variably with the wider COL4A1 spectrum. COL4A1 encodes the alpha-1 chain of the alpha1-alpha1-alpha2 type IV collagen heterotrimer. Pathogenic variants commonly alter triple-helical glycine residues, but splice, initiation-codon, truncating and other variants also occur. Intracellular retention, quantitative collagen deficiency, abnormal extracellular networks and altered vascular signaling contribute in variant- and tissue-dependent combinations. Clinical severity is highly variable within families. Hemorrhage can be spontaneous or modified by trauma, anticoagulant exposure and other vascular risks. Management is multidisciplinary surveillance, risk reduction and treatment of individual manifestations; mechanism-directed therapies remain experimental.

Ask OpenScientist

Ask a research question about Brain Small Vessel Disease 1 With Or Without Ocular Anomalies. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🔗

Mappings

MONDO

MONDO:0008289 brain small vessel disease 1 with or without ocular anomalies

MONDO:0008289 is the exact disease concept — an autosomal dominant familial porencephaly / brain small-vessel disease caused by mutation in COL4A1, variably associated with ocular anomalies (OMIM:175780).

👪

Inheritance

Autosomal dominant HP:0000006

Autosomal dominant inheritance with a 50% transmission risk for each child of a heterozygous individual. Inherited and de novo variants both occur. The GeneReviews estimate of at least 27% de novo cases reflects historically ascertained families rather than a fixed population rate. Clinical expression is highly variable; an asymptomatic carrier with abnormal brain MRI still has a detectable manifestation. Overall penetrance is not precisely established across variants, ages and organs.

Autosomal dominant inheritance

Show evidence (4 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"COL4A1-related disorders are inherited in an autosomal dominant manner."

GeneReviews establishes autosomal dominant inheritance.

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"The proportion of cases caused by a de novo pathogenic variant is estimated to be at least 27%."

Quantifies the de novo fraction.

PMID:16107487 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The last mutation was also present in an asymptomatic obligate carrier with white matter abnormalities on brain magnetic resonance imaging."

Clinically asymptomatic carriage with an MRI abnormality demonstrates variable expression; it does not by itself prove complete nonpenetrance.

+ 1 more reference

Discussions and Knowledge Gaps

Which COL4A1 variants and tissues are driven predominantly by intracellular retention, quantitative deficiency or extracellular mutant-collagen dysfunction?

KNOWLEDGE GAP OPEN bsvd1_intracellular_vs_extracellular_mechanism

Attached to

pathophysiology#Intracellular Collagen IV Retention pathophysiology#Abnormal Extracellular Collagen IV Network

Human haploinsufficiency, secretion-impaired mouse alleles, lenses without measurable UPR, and mutation-dependent chaperone benefit or harm demonstrate that a single retention-to-apoptosis pathway is insufficient. Retinal NOTCH3/TGF-beta, arterial PIP2/calcium and human iPSC metalloproteinase findings identify further context-dependent branches. Their relative contributions in individual patients remain uncertain.

Show evidence (2 references)

PMID:31051113 SUPPORT DIRECT PRIMARY RESULT Model Organism

"can ameliorate or exacerbate myopathy in a mutation-dependent manner"

Contrasting preclinical treatment response motivates genotype and tissue stratification.

PMID:23065703 SUPPORT DIRECT PRIMARY RESULT In Vitro

"nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs) and a clear reduction of COL4A1 protein expression were demonstrated"

Human quantitative deficiency provides a distinct mechanistic case.

⚙

Pathophysiology

Pathogenic COL4A1 Variation

Heterozygous germline COL4A1 variants perturb alpha1-alpha1-alpha2 collagen IV production or function. Glycine substitutions and in-frame splice defects can compromise heterotrimers, whereas some truncating or splice variants reduce transcript and protein abundance. These alternatives are not assumed to act identically.

COL4A1 hgnc:2202

extracellular matrix structural constituent GO:0005201 ⚠ ABNORMAL

Experimental models

COL4A1 haploinsufficiency patient fibroblasts PRIMARY CELL CULTURE Distinguishes quantitative loss from mutant-protein retention.

Downstream

Intracellular Collagen IV Retention Misfolded collagen accumulates intracellularly for secretion-impaired variants.

Abnormal Extracellular Collagen IV Network Variant-dependent quantitative and qualitative defects affect the extracellular network.

Abnormal Ocular Anterior Segment Development Conditional lens expression of mutant Col4a1 causes ocular dysgenesis.

Show evidence (2 references)

PMID:16107487 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"There were two missense mutations of glycine residues predicted to result in abnormal collagen IV assembly, and one mutation predicted to abolish the traditional COL4A1 start codon."

Human families establish variant heterogeneity; assembly effects were predicted.

PMID:23065703 SUPPORT DIRECT PRIMARY RESULT In Vitro

"nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs) and a clear reduction of COL4A1 protein expression were demonstrated"

Patient fibroblast protein reduction supports the quantitative-deficiency arm.

Intracellular Collagen IV Retention

Mutant and coassembled collagen IV can accumulate in the endoplasmic reticulum at the expense of secretion. Severity varies with allele and cell type. In the delta-exon-41 mouse, reducing intracellular accumulation protected against hemorrhage without necessarily restoring extracellular abundance or vascular branching.

endothelial cell CL:0000115 pericyte CL:0000669

Animal models

Col4a1 delta-exon-41 constitutive and conditional mice Mouse partially recapitulates Conditional and strain comparisons implicate retention in hemorrhage susceptibility.

Downstream

Endoplasmic Reticulum Stress Retention can elicit a stress response in susceptible tissues and variants.

Abnormal Extracellular Collagen IV Network Impaired export can reduce basement-membrane collagen deposition.

Cerebral Microvascular Fragility Reducing retention diminishes hemorrhagic susceptibility in a mouse model; intervening events are incompletely resolved.

Show evidence (2 references)

PMID:15905400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"inhibits the secretion of mutant and normal type IV collagen."

Dominant mutant mouse allele affects secretion of coassembled collagen.

PMID:25753534 SUPPORT DIRECT PRIMARY RESULT Model Organism

"intracellular accumulation of mutant collagen in vascular endothelial cells and pericytes was a key triggering factor of ICH"

Mouse genetic and pharmacologic comparisons implicate retention without proving a universal ER-stress cascade.

Endoplasmic Reticulum Stress

Unfolded-protein responses occur in selected collagen IV cellular and animal models, but intracellular retention does not invariably activate measurable ER stress. The COL4A2 G702D fibroblast study is comparative evidence, not direct proof in COL4A1 cerebral endothelium. Col4a1 mutant lenses accumulated collagen without detectable UPR activation. ER stress therefore cannot be assigned as the obligatory link to all vascular or ocular disease.

response to endoplasmic reticulum stress GO:0034976 ↑ INCREASED

Downstream

Impaired Sarcoplasmic Reticulum Calcium Release In the G1344D mouse, ER/SR dysfunction is proposed to impair calcium release; causation is not established across alleles.

Renal Tubular Cell Loss Chronic renal ER stress is proposed to promote tubular cell loss; stress and apoptosis precede or accompany medullary atrophy.

Show evidence (3 references)

PMID:24001601 SUPPORT INDIRECT PRIMARY RESULT In Vitro

"This intracellular accumulation led to ER stress, unfolded protein response activation, reduced cell proliferation and increased apoptosis."

Patient COL4A2 fibroblasts; indirect relevance to this COL4A1 entry.

PMID:28237965 REFUTE DIRECT PRIMARY RESULT Model Organism

"we did not detect evidence of UPR activation"

Negative lens result limits a universal retention-to-UPR mechanism.

PMID:26839400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"medullary atrophy was associated with chronic ER stress"

Direct COL4A1 mouse renal evidence complements comparative COL4A2 fibroblast findings.

Abnormal Extracellular Collagen IV Network

Collagen IV abundance, assembly and network quality may be altered independently. Human kidney and skin show thickening, duplication and disorganization; mouse vessels can show focal discontinuities. Increasing secretion need not restore mechanical stability if mutant collagen enters the matrix.

Animal models

Col4a1 multifunction fluorescent-tag and conditional-null mouse Mouse perturbs Tests matrix turnover and quantitative loss, rather than a misfolded dominant protein.

Downstream

Increased TGF-beta Signaling Altered matrix regulation is a candidate upstream explanation for increased TGF-beta activity; ligand availability was not directly established.

Increased NOTCH3 Signaling Reduced extracellular collagen in transitional segments may release restraint on NOTCH3, but the molecular link remains uncertain.

Increased Matrix Metalloproteinase Activity Mural-cell matrix defects accompany differentiation-dependent metalloproteinase dysregulation.

Cerebral Microvascular Fragility Loss of vascular basement-membrane integrity contributes to bleeding susceptibility.

Renal Basement Membrane Abnormality Systemic collagen defects involve renal basement membranes.

Skeletal Muscle Basement Membrane Dysfunction Muscle matrix dysfunction contributes to myopathy, with variant-dependent extracellular toxicity.

Abnormal Cerebral Vascular Development Extracellular dysfunction is proposed to perturb vascular patterning independently of retention burden.

Show evidence (2 references)

PMID:18160688 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Histologic analysis revealed complex basement-membrane defects in kidney and skin."

Direct human ultrastructural findings; organ-specific effects vary.

PMID:30351356 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the persistence of defects in BM structure and reduced ability of the BM to withstand mechanical stress"

Chaperone-treated mutant mice retain abnormal basement-membrane structure.

Abnormal Cerebral Vascular Development

Embryonic Col4a1 delta-exon-41 mice develop excessive, tortuous cerebral vessels. Vascular patterning defects can persist when interventions reduce intracellular collagen accumulation and hemorrhage. Early developmental requirements do not imply that adult collagen maintenance is dispensable.

Animal models

Col4a1 delta-exon-41 constitutive and conditional mice Mouse partially recapitulates Embryonic vascular architecture differs from controls.

Downstream

Cerebral Microvascular Fragility Abnormal vascular development contributes to the substrate for later hemorrhage in this allele.

Show evidence (1 reference)

PMID:25753534 SUPPORT DIRECT PRIMARY RESULT Model Organism

"increased vessel density and tortuosity in Col4a1+/Δex41 hindbrains"

Embryonic vascular-development result.

Increased TGF-beta Signaling

TGF-beta target-gene and reporter activity are increased in Col4a1 mutant models. Reduced Tgfb1 dosage improves several vascular and hemorrhagic outcomes, but not every challenge or developmental abnormality. Whole-brain phospho-SMAD measurements were not uniformly significant. This signaling branch is supported preclinically and is not equated with a demonstrated TGF-beta-to-NOTCH3 cascade.

Downstream

Arteriolar Smooth Muscle Cell Loss Reduced Tgfb1 dosage preserves mural coverage in mutant mice, implicating signaling in degeneration.

Reduced Smooth Muscle PIP2 Availability TGF-beta receptor and PI3K inhibitor rescue supports a TGF-beta–PI3K–PIP2 pathway in aged G394V arteries.

Abnormal Ocular Anterior Segment Development Reducing TGF-beta signaling partially rescues ocular development in mutant mice.

Show evidence (1 reference)

PMID:36435425 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Tgfb1 heterozygosity significantly reduced ICH severity in P7 and 1MO Col4a1+/G1344D mice"

Genetic perturbation in Col4a1 mutant mice supports a pathogenic contribution of TGF-beta signaling.

Increased NOTCH3 Signaling

NOTCH3 target-gene activation is enriched in transitional microvessels of Col4a1 G498V mice. Reducing Notch3 dosage attenuates transitional muscularization and hemorrhage, while arteriolar smooth-muscle loss persists.

Downstream

Transitional Vessel Hypermuscularization Notch3 genetic reduction suppresses excess transitional mural-cell number and contractile-protein expression.

Show evidence (1 reference)

PMID:32183562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"7 out of 11 of these Notch3 target genes were upregulated in brain microvessels"

Mouse microvessels enriched for transitional segments; not uniform upregulation in arteries.

Transitional Vessel Hypermuscularization

Transiently increased mural-cell proliferation produces excess muscular coverage of the arteriole-capillary transition in G498V and G1064D mice. Ex vivo retinal transitional segments show increased tone and contraction. Increased upstream pressure is a computational prediction; it was not directly measured in vivo.

Animal models

Col4a1 G498V and G1064D cerebroretinal vascular models Mouse perturbs Models excess transitional muscular coverage and its genetic suppression.

Downstream

Cerebral Microvascular Fragility Excess downstream resistance is predicted to raise pressure in upstream arteries weakened by smooth-muscle loss.

Show evidence (1 reference)

PMID:32183562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"this TS was hypermuscularized, with a hyperplasia of mural cells expressing more contractile proteins"

Distinct mural-cell population at the arteriole-capillary transition in mutant mice.

Arteriolar Smooth Muscle Cell Loss

Focal and segmental arteriolar smooth-muscle loss weakens arteries in mouse models. Its persistence despite protective Notch3 reduction shows that smooth-muscle loss alone is insufficient to explain all hemorrhage risk.

Animal models

Col4a1 G498V and G1064D cerebroretinal vascular models Mouse partially recapitulates Anatomically separate arterial degeneration persists after Notch3 reduction.

Downstream

Cerebral Microvascular Fragility Loss of mural support contributes to wall vulnerability together with other vascular defects.

Show evidence (1 reference)

PMID:32183562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"whereas the upstream arteriole exhibited a loss of SMCs."

Anatomically distinct arterial smooth-muscle loss accompanies transitional hypermuscularization.

Reduced Smooth Muscle PIP2 Availability

Reduced PIP2 availability is inferred from lipid-dialysis and PI3K-blockade rescue in 12-month-old G394V smooth-muscle cells. ATP levels were unchanged. This mechanism differs from the G1344D calcium-release defect and should not be generalized to every COL4A1 variant.

Downstream

Reduced TRPM4 Channel Activity Reduced availability of the PIP2 cofactor diminishes channel activity.

Show evidence (1 reference)

PMID:36693102 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Dialyzing SMCs with PIP2 and selective blockade of phosphoinositide 3-kinase (PI3K)"

Pharmacologic and lipid-dialysis rescue supports reduced PIP2 availability; depletion was inferred rather than directly quantified. Readout obtained from isolated mutant-mouse vessels or cells.

Impaired Sarcoplasmic Reticulum Calcium Release

In aged G1344D mice, vascular smooth-muscle calcium sparks and evoked sarcoplasmic-reticulum release are reduced. Reduced store content is inferred, not directly measured. TRPM4 currents elicited with high intracellular calcium remain intact, favoring impaired activation over loss of channels.

Animal models

Col4a1 G394V and G1344D age-dependent arterial dysfunction models Mouse partially recapitulates G1344D provides a distinct calcium-release mechanism.

Downstream

Reduced TRPM4 Channel Activity Reduced calcium delivery limits calcium-dependent TRPM4 activation in the G1344D model.

Show evidence (1 reference)

PMID:37963192 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the release of SR Ca2+ from RyRs is impaired in the SMCs of Col4a1+/G1344D mice in an age-dependent manner."

Mouse vascular smooth-muscle calcium-release finding; the size of the store is inferred. Readout obtained from isolated mutant-mouse vessels or cells.

Reduced TRPM4 Channel Activity

Depolarizing monovalent-cation currents through TRPM4 are reduced in selected aged Col4a1 mutant arterial smooth-muscle cells. G394V PIP2-dependent dysfunction and G1344D calcium-release-dependent dysfunction are distinct upstream routes. TRPM4 itself is not calcium-permeable.

Downstream

Impaired Cerebral Arterial Myogenic Tone Loss of depolarizing current reduces voltage-dependent calcium entry and pressure-induced contraction.

Show evidence (1 reference)

PMID:36693102 SUPPORT DIRECT PRIMARY RESULT In Vitro

"a significant decrease in depolarizing cation currents conducted by TRPM4"

Direct electrophysiology in 12-month-old Col4a1 G394V arterial smooth muscle. Readout obtained from isolated mutant-mouse vessels or cells.

Impaired Cerebral Arterial Myogenic Tone

Pressure-induced constriction is reduced in aged mutant cerebral arteries despite preserved passive diameter and high-potassium contraction. This impairs a component of autoregulation. It is anatomically and experimentally distinct from increased contraction of transitional segments in other alleles.

Animal models

Col4a1 G394V and G1344D age-dependent arterial dysfunction models Mouse partially recapitulates Models age-dependent arterial contractile dysfunction.

Downstream

Cerebral Microvascular Fragility Impaired autoregulation may expose downstream vessels to perfusion-pressure fluctuations; its precise contribution to human hemorrhage remains unresolved.

Show evidence (1 reference)

PMID:36693102 SUPPORT DIRECT PRIMARY RESULT In Vitro

"is blunted in cerebral arteries from middle-aged (12 mo old) but not young adult (3 mo old) animals"

Age-dependent pressure myography result in Col4a1 G394V mice. Readout obtained from isolated mutant-mouse vessels or cells.

Increased Matrix Metalloproteinase Activity

Patient-derived COL4A1 G755R and comparative COL4A2 G702D mural-cell models have dysregulated MMP expression/activity. MMP2 is reduced early and elevated after maturation; MMP9 is increased later and MMP7 earlier. Pharmacologic inhibition partially rescues matrix and cellular abnormalities. Zebrafish col4a1 loss also increases mmp9 transcription.

Experimental models

Human COL4A1/COL4A2 iPSC mural–endothelial co-cultures CO CULTURE Provides drug perturbation of proteolytic matrix abnormalities.

Animal models

col4a1 crispant and stable delta20 zebrafish Zebrafish perturbs Tests the contribution of mmp9 in a whole-animal loss model.

Downstream

Endothelial Barrier Dysfunction Mural-cell paracrine effects and inhibitor rescue implicate metalloproteinases in endothelial-junction dysfunction.

Show evidence (2 references)

PMID:37977146 SUPPORT DIRECT PRIMARY RESULT In Vitro

"COL4A1/A2 models also express high levels of matrix metalloproteinases (MMPs)"

Human iPSC-derived mural cultures; expression differs by enzyme and differentiation stage.

PMID:40846110 SUPPORT DIRECT PRIMARY RESULT Model Organism

"elevated matrix metalloproteinase 9 (mmp9) transcription associated with loss of col4a1."

Transcript finding in a zebrafish loss-of-function model, not direct enzyme activity in patients.

Endothelial Barrier Dysfunction

Mutant human iPSC-derived mural cells disrupt endothelial junctions and barrier measurements in culture. Brain-endothelial-like cells in this protocol have epithelial identity limitations; validation in generic endothelial cells supports junction effects but lacks full BBB function. This is context-dependent: tracer studies in the earlier delta-exon-41 mouse did not detect a generalized barrier defect.

Experimental models

Human COL4A1/COL4A2 iPSC mural–endothelial co-cultures CO CULTURE Tests mural-cell paracrine injury to endothelial junctions.

Downstream

Cerebral Microvascular Fragility Mural–endothelial dysfunction is a candidate additional contributor to microvascular vulnerability, with in-vivo applicability still under study.

Show evidence (2 references)

PMID:37977146 SUPPORT DIRECT PRIMARY RESULT In Vitro

"these mural cell defects exert a detrimental effect on endothelial cell tight junctions through paracrine actions."

Co-culture and conditioned-medium evidence, with limitations in the endothelial differentiation protocols.

PMID:25753534 REFUTE DIRECT PRIMARY RESULT Model Organism

"Cerebral and retinal vessels were not permeable to biotin, Evans blue dye or sodium fluorescein and tight junction proteins were normally expressed during brain development"

The full tracer experiments found retained barrier integrity despite hemorrhagic susceptibility.

Cerebral Microvascular Fragility

Defective basement membranes, mural-cell support and vascular regulation create susceptibility to cerebral vessel disruption. The relative contributions depend on allele, developmental stage and vessel segment. A separate adult endothelial Col4a1-depletion model produces microbleeds without macrohemorrhage or white-matter lesions.

Animal models

Adult brain endothelial Col4a1 editing mouse Mouse perturbs Tests adult endothelial matrix dependence with a microbleed endpoint.

Downstream

Cerebral Hemorrhagic Injury Vulnerable cerebral microvessels can bleed spontaneously or after additional stress.

Show evidence (2 references)

PMID:15905400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"porencephaly secondary to focal disruptions of vascular basement membranes."

Founding mouse model establishes a vascular structural lesion.

PMID:42225261 SUPPORT DIRECT PRIMARY RESULT Model Organism

"significant basement membrane thinning in Col4a1-depleted microvessels."

Adult targeted-deletion model supports a maintenance role, without reproducing the germline missense mechanism.

Cerebral Hemorrhagic Injury

Cerebral bleeding ranges from prenatal parenchymal injury and microhemorrhage to recurrent symptomatic intracerebral hemorrhage. Resorption of early destructive injury can leave porencephalic cavities. Hemorrhage is not required to explain every white-matter or systemic feature.

Downstream

Intracerebral hemorrhage Clinical expression of parenchymal bleeding.

Cerebral microbleeds Small hemorrhagic deposits are detectable by MRI.

Porencephaly Destructive prenatal/perinatal hemorrhage can evolve into a cystic cavity.

Infantile hemiparesis Early destructive brain injury can contribute to this manifestation; other mechanisms and variable severity remain possible.

Seizures Early destructive brain injury can contribute to this manifestation; other mechanisms and variable severity remain possible.

Intellectual disability Early destructive brain injury can contribute to this manifestation; other mechanisms and variable severity remain possible.

Show evidence (1 reference)

PMID:16598045 SUPPORT DIRECT PRIMARY RESULT Model Organism

"predisposes both newborn and adult mice to intracerebral hemorrhage."

Mouse hemorrhage phenotype at multiple ages.

Abnormal Ocular Anterior Segment Development

Conditional lens expression of mutant Col4a1 causes cataract and dose-dependent abnormalities in adjacent anterior structures. Lens-autonomous and nonautonomous effects coexist; direct UPR activation was not detected in the studied lenses. Human anterior-segment dysgenesis includes Axenfeld-Rieger-type findings and may accompany glaucoma.

Animal models

Col4a1 delta-exon-41 constitutive and conditional mice Mouse partially recapitulates Lens-restricted perturbation causes partial ocular disease.

col4a1 morphant and multiplex crispant zebrafish Zebrafish partially recapitulates Models selected ocular defects and allele-dependent developmental rescue.

Downstream

Axenfeld-Rieger anomaly COL4A1 ocular dysgenesis includes this clinical pattern.

Cataract Lens pathology produces developmental cataract.

Show evidence (2 references)

PMID:28237965 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Mice with lens-specific expression of mutant Col4a1 had cataracts"

Conditional mouse expression separates lens pathology from broader vascular injury.

PMID:17696175 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Diffuse leukoencephalopathy associated with ocular malformations of the Axenfeld-Rieger type was observed in five individuals."

Human clinical association.

Renal Basement Membrane Abnormality

Human COL4A1 renal disease includes basement-membrane thickening and disorganization in tubules, Bowman capsule and interstitial capillaries. The anatomic evidence does not justify assigning all hematuria specifically to glomerular basement-membrane disruption.

Downstream

Hematuria Hematuria accompanies the renal basement-membrane phenotype; the exact bleeding site is not established.

Renal cysts Cystic disease is part of the renal phenotype.

Show evidence (1 reference)

PMID:18160688 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Histologic analysis revealed complex basement-membrane defects in kidney and skin."

Direct human ultrastructural findings; organ-specific effects vary.

Skeletal Muscle Basement Membrane Dysfunction

Muscular, vascular and peripheral-nerve contributions to neuromyopathy can be separated in conditional mice. Extracellular mutant collagen may damage muscle even when increasing secretion benefits peripheral myelination. These experiments do not establish one uniform mechanism for human cramps.

Downstream

Muscle cramps Muscle disease is a plausible contributor to cramps; the precise human mechanism remains unresolved.

Show evidence (1 reference)

PMID:31051113 SUPPORT DIRECT PRIMARY RESULT Model Organism

"independent muscular, neural, and vascular insults contribute to neuromyopathy"

Separate contributions demonstrated in conditional mouse models.

Renal Tubular Cell Loss

Col4a1 Raw/Svc mice develop renal stress-marker activation and apoptotic signals associated with medullary atrophy and impaired urinary concentration. In this study tubular basement membranes appeared structurally preserved, distinguishing this compartment from Bowman-capsule and glomerular matrix defects. The mouse findings do not establish universal diabetes insipidus or progressive renal failure in human BSVD1.

Animal models

Col4a1 Raw and Svc renal models Mouse partially recapitulates Models a tissue-specific intracellular-stress contribution to renal disease with important human-fidelity limits.

Show evidence (1 reference)

PMID:26839400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"All 3- to 4-month-old Col4a1+/Raw mice also expressed cleaved caspase 3"

Renal apoptotic marker accompanies the chronic stress response; causality is supported by temporal association rather than selective pathway rescue.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Blood 4

Intracerebral hemorrhage HP:0001342

Show evidence (2 references)

PMID:16598045 SUPPORT DIRECT PRIMARY RESULT Model Organism

"predisposes both newborn and adult mice to intracerebral hemorrhage."

Establishes hemorrhage predisposition across ages.

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"A history of stroke was reported in 9 subjects (17.3%); in 6 cases it was attributable to subcortical hemorrhage and in 3 cases it was attributable to lacunar infarction."

Six hemorrhagic and three ischemic strokes in an ascertained 52-carrier series; total stroke frequency is not hemorrhage frequency.

Cerebral microbleeds Cerebral hemorrhage HP:0001342

Show evidence (1 reference)

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"microbleeds that are usually subcortical (52.9%),"

Describes an imaging finding in selected reported carriers; not an unselected population prevalence.

Hemolytic anemia HP:0001878

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"cardiac arrhythmia, and hemolytic anemia"

GeneReviews lists hemolytic anemia among systemic findings.

Retinal hemorrhage HP:0000573

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Affected individuals experience episodic transient visual loss as a result of retinal hemorrhage occurring spontaneously or after minor stress or trauma."

Full chapter directly links the retinal finding to transient symptoms.

Cardiovascular 7

Ischemic stroke Lacunar stroke HP:0032325

Show evidence (1 reference)

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"in 3 cases it was attributable to lacunar infarction."

Clinical stroke attribution in three of 52 literature cases; distinct from silent imaging lacunes and not an unbiased population estimate.

Intracranial aneurysm Dilatation of the cerebral artery HP:0004944

Show evidence (1 reference)

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Asymptomatic intracranial aneurysms were common (44.4% of 18 with angiography)."

Eight of eighteen angiographically investigated carriers, with screening-selection limitations.

Retinal arterial tortuosity HP:0000631

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract)"

GeneReviews lists retinal arterial tortuosity among the ocular defects.

Raynaud phenomenon HP:0030880

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia)"

GeneReviews lists Raynaud phenomenon among systemic findings.

Cardiac arrhythmia HP:0011675

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"cardiac arrhythmia, and hemolytic anemia"

GeneReviews lists cardiac arrhythmia among systemic findings.

Dilated perivascular spaces Dilation of Virchow-Robin spaces HP:0012520

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages."

GeneReviews imaging spectrum.

Mitral valve prolapse HP:0001634

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Mitral valve prolapse and supraventricular arrythmia have been characterized in four patients"

Full chapter describes both findings in a small reported set.

Digestive 1

Feeding difficulties HP:0011968

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Feeding difficulties, conversely, were common (9/17, 53%) with frequent placement of surgical feeding tubes (6/17, 35%)."

Direct clinical observation in a selected early-onset group.

Ear 1

Sensorineural hearing impairment HP:0000407

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we identified 2 adolescents with sensorineural hearing loss in addition to neuroimaging and renal features typical of COL4A1/2-related disorders."

Full Table 1 places both in the COL4A1 late-childhood subgroup; a new, limited observation.

Eye 4

Axenfeld-Rieger anomaly Ocular anterior segment dysgenesis HP:0007700

Show evidence (1 reference)

PMID:17696175 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Diffuse leukoencephalopathy associated with ocular malformations of the Axenfeld-Rieger type was observed in five individuals."

Documents the Axenfeld-Rieger anomaly in a COL4A1 family.

Cataract Developmental cataract HP:0000519

Show evidence (1 reference)

PMID:24374867 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We report two cases of prenatal ICH associated with cataract and suggest that COL4A1 mutation should be envisaged in fetuses with prenatal ICH, especially in the presence of lens abnormalities at ultrasound examination."

Associates cataract with prenatal COL4A1 disease.

Glaucoma HP:0000501

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"posterior embryotoxon, microcornea, increased intraocular pressure, and glaucoma."

Human clinical spectrum summarized in GeneReviews; no COL4A1-specific 50–75% risk is asserted.

Microphthalmia HP:0000568

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"including cataracts, glaucoma, microphthalmia, and anterior segment dysgenesis"

Ophthalmologic findings in the COL4A1 perinatal subgroup.

Genitourinary 4

Hematuria HP:0000790

Show evidence (1 reference)

PMID:18160688 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The clinical renal manifestations of the HANAC syndrome in these families include hematuria and bilateral, large cysts."

Documents hematuria as a renal manifestation.

Renal cysts HP:0000107

Show evidence (1 reference)

PMID:18160688 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"hematuria and bilateral, large cysts."

Documents bilateral renal cysts.

Unilateral renal atrophy HP:0008717

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Unilateral renal atrophy ... has been reported in two individuals"

Specific full-chapter renal finding.

Decreased glomerular filtration rate HP:0012213

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Glomerular filtration rate decrease ... has been observed in individuals with HANAC"

Age-qualified renal observation from the full chapter.

Metabolism 1

Elevated creatine kinase Elevated circulating creatine kinase activity HP:0003236

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"serum CK elevation with or without muscle cramps"

Directly states the laboratory finding; not inferred solely from the presence of myopathy.

Musculoskeletal 2

Muscle cramps Muscle spasm HP:0003394

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia)"

GeneReviews lists muscle cramps among systemic findings.

Intracerebral calcification HP:0002514

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"deep intracerebral hemorrhages, and intracerebral calcifications"

Full GeneReviews description of the BSVD imaging pattern.

Nervous System 11

Porencephaly Porencephalic cyst HP:0002132

Show evidence (2 references)

PMID:16107487 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"This observation confirms COL4A1 as a major locus for genetic predisposition to perinatal cerebral haemorrhage and porencephaly"

Confirms COL4A1 as a major cause of hereditary porencephaly.

PMID:15905400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"approximately 18% of survivors had porencephaly."

Recapitulation of porencephaly in the Col4a1 mouse model.

Infantile hemiparesis HP:0001269

Onset: INFANTILE

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura."

GeneReviews lists infantile hemiparesis as a core manifestation.

Seizures HP:0001250

Show evidence (2 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability"

GeneReviews lists seizures among porencephaly manifestations.

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Epilepsy was seen in 8/17 (47%) and treatment refractory in most (6/8, 75%)."

COL4A1 perinatal-onset subgroup of a retrospective pediatric cohort.

Intellectual disability HP:0001249

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability"

GeneReviews lists intellectual disability among porencephaly manifestations.

Leukoencephalopathy HP:0002352

Show evidence (1 reference)

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Brain imaging showed frequent leukoaraiosis (63.5%),"

Describes an imaging finding in selected reported carriers; not an unselected population prevalence.

Migraine with aura HP:0002077

Show evidence (1 reference)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"ischemic stroke, and isolated migraine with aura."

GeneReviews explicitly identifies migraine with aura.

Dystonia HP:0001332

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"infantile hemiparesis, seizures, intellectual disability, dystonia, stroke, and migraine."

GeneReviews clinical manifestations.

Global developmental delay HP:0001263

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Developmental delays were seen in most patients (15/17, 88%) and were frequently global (11/17, 65%)."

COL4A1 perinatal subgroup.

Cerebral palsy HP:0100021

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"CP diagnosis was common (11/17, 65%) and frequently severe (7/17 with GMFCS ≥4, 41%)"

COL4A1 perinatal subgroup; not combined-gene prevalence.

Ventriculomegaly HP:0002119

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Ventriculomegaly was common (13/17, 76%) with posthemorrhagic hydrocephalus in 3 patients"

Imaging findings in the COL4A1 perinatal subgroup.

Schizencephaly HP:0010636

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Schizencephaly and porencephaly were evident in some (4/17, 24%, and 9/17, 53%, respectively)."

COL4A1 perinatal subgroup imaging.

🧬

Genetic Associations

COL4A1

Gene: COL4A1 hgnc:2202 gene page relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (4 references)

PMID:27794444 SUPPORT DIRECT REVIEW SYNTHESIS Other

"glycine (Gly) substitutions within the triple helical domain are the most common class of mutations."

Establishes glycine substitutions in the triple helix as the dominant variant class.

PMID:18160688 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We identified three closely located glycine mutations in exons 24 and 25 of the gene COL4A1, which encodes procollagen type IV alpha1."

Localizes the HANAC-associated variants to exons 24-25.

PMID:25719457 SUPPORT DIRECT BACKGROUND Human Clinical

"Since 2005, COL4A1 mutations have been known as an autosomal dominant cause of hereditary porencephaly."

Establishes COL4A1 as the causative autosomal dominant gene.

+ 1 more reference

FN1 candidate modifier

Gene: FN1 hgnc:3778 gene page relationship_type: MODIFIER

Show evidence (2 references)

PMID:34424299 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Of the four positional candidate genes that were differentially expressed, Fn1 is a strong functional candidate."

Expression and functional considerations nominate Fn1 within the mouse modifier interval; single-gene causality and human modification remain unproven.

PMID:34424299 REFUTE DIRECT PRIMARY RESULT Model Organism

"MoGS1 had no effect on ICH"

Counterevidence to modification of intracerebral hemorrhage by the interval; it does not refute ocular or muscle modification or establish which gene drives it.

💊

Medical Actions

Supportive and rehabilitative care

Action: Therapeutic Procedure NCIT:C49236

Platform: Other

Individualized care addresses motor disability, development, communication and practical family support. Feeding assessment and enteral access may be needed in children with severe neurologic impairment. This is a multidisciplinary intervention rather than a purely behavioral treatment.

Show evidence (2 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Supportive care tailored to the individual’s specific medical needs and including practical help and emotional support for affected individuals and their families."

GeneReviews general management.

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Feeding difficulties, conversely, were common (9/17, 53%) with frequent placement of surgical feeding tubes (6/17, 35%)."

Clinical use of feeding support in the COL4A1 perinatal subgroup.

Seizure treatment

Action: Therapeutic Procedure NCIT:C49236

Platform: Other

Antiseizure treatment follows the seizure syndrome and individual response. A pediatric COL4A1 cohort also reported ketogenic diet and epilepsy surgery in selected refractory cases; these observations do not establish one preferred drug or procedure for all carriers.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Seizures are managed using standard protocols."

GeneReviews treatment recommendation.

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"including ketogenic diet (3/5, 60%) and epilepsy surgery (3/5, 60%)."

Selected children with epilepsy in the early-childhood COL4A1 subgroup.

Blood-pressure control

Action: Pharmacotherapy NCIT:C15986

Platform: Small molecule

Treat hypertension and monitor blood pressure to reduce vascular risk. The 2025 consensus also emphasizes peri-procedural pressure support. Benefit is based on risk-management guidance, not a COL4A1-specific randomized antihypertensive trial.

Show evidence (2 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Hypertension should be treated to reduce the overall risk of stroke."

GeneReviews recommendation.

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Other

"consider strict peri-procedural blood pressure support"

Consensus recommends attention to pressure during procedures.

Hemorrhage-risk reduction and individualized antithrombotic decisions

Action: Therapeutic Procedure NCIT:C49236

Platform: Behavioral / lifestyle

Avoid smoking and head trauma, and avoid prolonged strenuous exertion while maintaining appropriate aerobic activity. Antiplatelet and anticoagulant treatment is generally discouraged for routine prevention, but a strong competing indication or ischemic stroke without prior intracranial hemorrhage warrants multidisciplinary assessment. This is not an absolute prohibition under all circumstances.

Show evidence (3 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Avoiding head trauma and anticoagulant exposure may decrease the risk for intracerebral hemorrhage."

GeneReviews precaution.

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Other

"beneﬁts should be discussed with a multidisciplinary team in cases of ischemic stroke"

2025 consensus explicitly allows individualized assessment of competing indications.

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Other

"Continue aerobic exercise while avoiding strenuous,"

Exercise guidance distinguishes appropriate aerobic activity from strenuous exertion.

Ophthalmologic treatment

Action: Therapeutic Procedure NCIT:C49236

Platform: Other

Treat cataract and glaucoma according to the affected structures and visual risk. Severe lens opacity may require cataract surgery. Glaucoma is initially treated with topical medication, with surgery when medical treatment is inadequate.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Cataract surgery may be required for individuals with severe lens opacities."

Specific clinical intervention in the full chapter.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Glaucoma is initially treated with topical anti-glaucoma medication. Surgery is reserved for eyes that do not respond to medical therapy."

GeneReviews stepwise glaucoma care.

Multiorgan surveillance

Action: Therapeutic Procedure NCIT:C49236

Platform: Other

Regular clinical follow-up and surveillance of neurologic, ophthalmic, renal and cardiac involvement are individualized. GeneReviews regards annual clinical review as reasonable and proposes imaging for aneurysm follow-up. The 2025 consensus proposes repeat adult vascular imaging about every five years when an aneurysm is absent, with closer follow-up when indicated; these are expert recommendations rather than validated universal intervals.

Show evidence (3 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Annual clinical evaluation is reasonable."

Full-chapter follow-up recommendation.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Regular brain imaging can be proposed, especially to evaluate the size of asymptomatic cerebral aneurysms."

Imaging surveillance recommendation.

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Other

"every 5 years, unless aneurysm is observed"

Consensus adult vascular-imaging interval, individualized if an aneurysm is present.

Symptomatic supraventricular arrhythmia treatment

Action: Pharmacotherapy NCIT:C15986

Agent: Beta-Adrenergic Antagonist NCIT:C29576

Platform: Small molecule

Beta-blocker treatment may be used for symptomatic paroxysmal supraventricular arrhythmia, with cardiac evaluation guiding management.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Symptomatic paroxysmal supraventricular arrhythmia should be treated with antiarrhythmic drugs (beta blockers)."

GeneReviews symptomatic treatment recommendation.

Renal management

Action: Therapeutic Procedure NCIT:C49236

Platform: Other

Renal follow-up includes filtration, blood pressure, urinalysis and imaging as indicated. Proteinuria prompts nephrology assessment and consideration of renin-angiotensin-aldosterone system blockade; reduced kidney function or cystic disease warrants specialist care. This is consensus-based clinical management, not a disease-specific drug trial.

Show evidence (1 reference)

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Other

"If proteinuria is present, refer the patient to a nephrologist"

2025 consensus recommendation for renal specialist management.

Intracranial aneurysm intervention

Action: Surgical Procedure NCIT:C15329

Platform: Surgery

Surgical or endovascular treatment is considered according to aneurysm anatomy, size and individual risk. GeneReviews discusses asymptomatic aneurysms larger than 10 mm; this is not a universal intervention threshold validated specifically for every COL4A1 carrier.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Surgical or endovascular treatment should be discussed for asymptomatic intracranial aneurysms ... 10.0 mm in diameter."

Full-chapter management guidance, explicitly attributed.

Genetic and reproductive counseling

Action: Genetic Counseling NCIT:C15240

Platform: Behavioral / lifestyle

Discuss autosomal dominant transmission, uncertain severity, family testing and reproductive options. Prenatal and preimplantation genetic testing can be considered once a familial pathogenic variant is known. The historical de novo fraction is not a recurrence-risk calculation.

Show evidence (2 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Each child of an individual with a COL4A1-related disorder has a 50% chance of inheriting the pathogenic variant."

Transmission risk differs from penetrance and severity.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"prenatal testing for a pregnancy at increased risk"

Full-chapter reproductive testing discussion; familial variant identification is required.

Individualized pregnancy and delivery planning

Action: Therapeutic Procedure NCIT:C49236

Platform: Other

A specialist obstetric and fetal/neonatal team should consider the maternal and fetal genotype and clinical condition. The 2025 consensus makes cesarean delivery a case-by-case option when mother or fetus carries a pathogenic variant, updating the blanket recommendation in the older GeneReviews chapter. A 2026 retrospective combined-gene pediatric study found no association between delivery mode and several childhood outcomes, but confounding by prenatal injury and small sample size prevent a conclusion of equivalent safety.

Show evidence (2 references)

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Other

"A cesarean delivery may be considered in a case-by- case basis when a mother or fetus has a known path- ogenic COL4A1 or COL4A2 variant."

Current expert-consensus qualification.

PMID:42605108 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"no association was detected between these diagnoses and delivery type."

Retrospective combined-gene observational evidence; no causal delivery comparison.

Sodium phenylbutyrate (preclinical)

Action: Pharmacotherapy NCIT:C15986

Agent: Sodium Phenylbutyrate NCIT:C1440

Platform: Small molecule

The chemical chaperone sodium 4-phenylbutyrate promotes collagen secretion and can reduce retention and selected disease outcomes in mice. Responses depend on mutation, tissue, dose and treatment timing. Delta-exon-41 myopathy improves, whereas G394V muscle histology worsens despite improved peripheral myelination. In G1064D mice, preventive treatment reduces MRI hemorrhage volume; adult treatment reduces histologic hemosiderin without a clear MRI burden change. Matrix structural defects persist and skin mechanical stability can worsen. Ocular rescue at high prenatal doses in another model coincides with maternal/perinatal toxicity. These findings do not establish human efficacy or a safe disease-specific regimen.

Mechanism Target:

MODULATES Intracellular Collagen IV Retention — Promotes export of retained collagen in responsive preclinical models; extracellular quality may remain abnormal.

Show evidence (5 references)

PMID:29895609 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We show the efficacy of long-term 4PBA treatment in reducing the severity of intracerebral hemorrhages (ICHs) in Col4a1 mutant mice aged up to 8 months."

Timing and dose experiments in mutant mice.

PMID:31051113 SUPPORT DIRECT PRIMARY RESULT Model Organism

"4PBA treatment exacerbated myopathy in Col4a1+/G394V mice"

Direct genotype-dependent preclinical harm.

PMID:30351356 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the persistence of defects in BM structure and reduced ability of the BM to withstand mechanical stress"

Abstract identifies matrix-related limitations; full text localizes mechanical testing to skin.

+ 2 more references

Matrix metalloproteinase inhibition (preclinical)

Action: Pharmacotherapy NCIT:C15986

Agent: Doxycycline NCIT:C457 Marimastat NCIT:C1652

Platform: Small molecule

Doxycycline and marimastat partially rescue matrix deposition, migration, apoptosis and endothelial-junction phenotypes in human iPSC-derived COL4A1/COL4A2 models. A zebrafish col4a1-loss study also reports partial vascular rescue after MMP9 inhibition. These culture and animal results do not establish clinical efficacy; the observational MMP biomarker study is not a drug trial.

Mechanism Target:

INHIBITS Increased Matrix Metalloproteinase Activity — Broad MMP inhibition tests a candidate proteolytic contribution in preclinical systems.

Show evidence (3 references)

PMID:37977146 SUPPORT DIRECT PRIMARY RESULT In Vitro

"inhibiting MMP activity partially rescues the ECM abnormalities and mural cell phenotypic changes."

Human-cell model result, not treated-patient evidence.

url:https://eprints.gla.ac.uk/309664/1/309664.pdf SUPPORT DIRECT PRIMARY RESULT In Vitro

"targeting MMPs using the pan-MMP inhibitor DOXY partially rescued the disease MC phenotypes"

Full-paper doxycycline result.

PMID:40846110 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Pharmacological inhibition of mmp9 was sufficient to ameliorate some cerebrovascular phenotypes."

Zebrafish loss model; no claim of complete rescue.

TGF-beta pathway inhibition (preclinical)

Action: Therapeutic Procedure NCIT:C49236

Agent: Losartan NCIT:C66869

Platform: Other

Genetic Tgfb1 reduction and a pan-TGF-beta antibody provide mouse proof of mechanism. Acute SB-431542 or PI3K inhibitor GSK1059615 restores myogenic tone at physiological, but not high, pressures in isolated G394V cerebral arteries. Gestational losartan improves corneal thickness in some alleles but increases postnatal death and does not clearly normalize the selected TGF-beta target genes; that regimen is not a viable therapy. No disease-specific human benefit has been established.

Mechanism Target:

MODULATES Increased TGF-beta Signaling — Preclinical genetic and pharmacologic perturbations support pathway involvement; losartan target-gene effects were inconclusive.

Show evidence (3 references)

PMID:36693102 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the myogenic tone was not improved at higher pressure levels"

Ex vivo pharmacologic rescue is pressure-limited.

PMID:35525525 SUPPORT DIRECT PRIMARY RESULT Model Organism

"gestational administration of losartan was also associated with increased postnatal death"

Mouse ocular intervention carries explicit toxicity and mechanistic uncertainty.

PMID:35525525 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we did not detect an effect of losartan on the expression of TGFβ target genes"

Losartan ocular protection does not prove suppression of the measured pathway targets.

🌍

Environmental Factors

Environmental "second hit" precipitants of hemorrhage

Trauma, intense exertion, anticoagulant exposure and vascular risk factors can modify hemorrhagic susceptibility; hemorrhage may also occur spontaneously or prenatally before delivery. These exposures are risk modifiers rather than required causes. Mouse surgical-delivery protection does not establish a universal human delivery recommendation.

Show evidence (2 references)

PMID:15905400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we propose that Col4a1 mutations conspire with environmental trauma in causing the disease."

Establishes the gene-environment (second-hit) model.

PMID:25753534 SUPPORT DIRECT PRIMARY RESULT Model Organism

"environmental factors such as intense exercise or anticoagulant medication modulated disease severity"

Identifies specific environmental modifiers of severity.

🔬

Diagnosis

COL4A1 molecular genetic testing

Diagnosis combines compatible clinical/imaging findings with a pathogenic or likely pathogenic COL4A1 variant. Multigene testing including COL4A1 and COL4A2 is useful because phenotypes overlap; negative testing with strong suspicion may justify broader genomic analysis, including poorly covered or intronic regions. A VUS alone is not confirmatory. Baseline multiorgan assessment is advised even when symptoms are mild.

Genetic Testing NCIT:C15709

Show evidence (2 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Diagnosis is based on clinical findings and molecular genetic testing of COL4A1."

GeneReviews diagnostic principle.

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Genome sequencing is recommended in patients with a nega- tive panel or exome if there is high suspicion"

Full consensus provides a conditional broader-testing strategy.

Fetal/neonatal imaging clue

Prenatal intracranial hemorrhage, especially with cataract or other lens abnormalities, should raise suspicion for COL4A1 disease. This combination is a diagnostic clue rather than a pathognomonic finding.

Show evidence (1 reference)

PMID:24374867 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"COL4A1 mutation should be envisaged in fetuses with prenatal ICH, especially in the presence of lens abnormalities at ultrasound examination."

Establishes the prenatal ICH-plus-cataract diagnostic clue.

Multiorgan baseline assessment

Brain MRI and head/neck vascular imaging, ophthalmologic assessment, renal imaging and renal-function/urine evaluation, CK measurement and cardiac assessment help define involvement. The 2025 consensus extends systematic cardiac screening to ECG and echocardiography. Choice and timing of repeated tests are individualized.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/ SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Measurement of serum CK concentration"

Full-chapter baseline assessment includes CK rather than inferring myopathy.

url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"Cardiovascular screening including blood pressure"

Expert-consensus baseline assessment; not a validated outcome-based screening trial.

🩻

Imaging Findings

Small-vessel disease on brain MRI

Brain MRI may show periventricular hemorrhagic infarction, porencephalic cavities, diffuse or patchy white-matter abnormality, lacunes, microbleeds and dilated perivascular spaces. Some clinically asymptomatic carriers have abnormal imaging. Dedicated vascular imaging assesses aneurysms and vessel tortuosity. The 2026 pediatric study adapted an injury-severity score from another population; it is not a validated diagnostic or prognostic score for COL4A1 disease.

Show evidence (2 references)

PMID:20301768 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages."

GeneReviews core imaging findings; variable clinical expression is described separately.

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"dilated perivascular spaces (19.2%)."

Quantifies dilated perivascular spaces among carriers.

📈

Progression

Prenatal / perinatal

Age: In utero to neonatal

Intracranial hemorrhage can occur antenatally (detectable on fetal ultrasound) or perinatally, precipitated by delivery, producing porencephaly, infantile hemiparesis, and seizures at the severe end.

Show evidence (1 reference)

PMID:24374867 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"several authors have reported mutations in COL4A1 as a Mendelian cause of prenatal onset intracranial hemorrhage (ICH)."

Documents the prenatal/perinatal onset window.

Childhood presentations

Age: Infancy through adolescence

A retrospective cohort distinguished perinatal, early-childhood and late-childhood presentations. Earlier onset correlated with greater neurologic impairment, whereas later presentations more often showed isolated leukoencephalopathy. These are provisional clinical strata, not validated molecular subtypes or inevitable sequential stages. Clinical onset must be distinguished from delayed genetic diagnosis.

Show evidence (1 reference)

PMID:42099677 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Perinatal and early childhood presentations exhibit a more prominent neurologic phenotype compared with late childhood presentations."

Combined-gene cohort conclusion, with gene-specific findings separately reported.

Adulthood

Age: Adult

In milder cases the disease presents in adulthood as small-vessel disease — ischemic or hemorrhagic stroke (mean stroke onset ~36 years), migraine, leukoencephalopathy, and aneurysms — sometimes as the first manifestation.

Show evidence (1 reference)

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"have been recently recognized as a further monogenic cause of small vessel disease that can present in adulthood."

Documents adult-onset small-vessel-disease presentation.

📊

Prevalence

Worldwide

Unknown

Population prevalence is not established. Published clinical series and literature compilations are ascertained, often combine COL4A1 and COL4A2, and have variable screening. Their case counts cannot support an ultra-rare numerical prevalence class.

Show evidence (1 reference)

PMID:39016117 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"43 individuals from 23 distinct families carrying pathogenic variants."

Size of an ascertained combined-gene clinical cohort, not a population estimate.

🔀

Differential Diagnoses

Conditions with similar clinical presentations that must be differentiated from Brain Small Vessel Disease 1 With Or Without Ocular Anomalies:

Other hereditary cerebral small-vessel diseases

Overlapping Features CADASIL (NOTCH3), CARASIL (HTRA1), and other monogenic small-vessel diseases share leukoencephalopathy and stroke; the presence of porencephaly, ocular anterior-segment anomalies, retinal arterial tortuosity, or the HANAC systemic features (hematuria, renal cysts, muscle cramps, aneurysms) points to COL4A1.

Show evidence (1 reference)

PMID:20558831 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"A number of single gene disorders can cause cerebral small vessel disease."

Situates COL4A1 among the monogenic small-vessel diseases requiring differentiation.

🔬

Clinical Trials

NCT01097564 COMPLETED

Prospective multicenter observational cohort characterizing clinical, imaging and mutational features of COL4A1 disease. It does not test a disease-modifying drug.

Show evidence (1 reference)

clinicaltrials:NCT01097564 SUPPORT DIRECT Other

"This prospective multicenter cohort study aims to define the clinical, radiological and mutational spectrum of the disease related to COL4A1 gene."

Registry study objective.

NCT07374913 RECRUITING

Observational diagnostic study of COL4A1/COL4A2 families, including eye/heart screening and blood MMP2/MMP9 analyses. Biomarker measurements are exploratory rather than validated diagnostic tests or evidence for an MMP inhibitor.

Show evidence (1 reference)

clinicaltrials:NCT07374913 SUPPORT DIRECT Other

"blood samples will be analyzed to study the activity of specific enzymes called matrix metalloproteinases (MMP2 and MMP9)"

Registry describes planned measurement, not a completed treatment result.

🧫

Experimental Models

Human COL4A1/COL4A2 iPSC mural–endothelial co-cultures CO_CULTURE

Neural-crest-derived mural cells are studied during differentiation and after maturation, with endothelial co-culture/conditioned-medium assays. Increased migration, later apoptosis, collagen-matrix abnormalities and stage-dependent MMP dysregulation are partially corrected by doxycycline or marimastat. Brain-endothelial-like cells have epithelial transcriptional features; generic endothelial validation lacks full BBB properties. The COL4A2 donor is an unaffected father, not the symptomatic child from the earlier fibroblast study.

Organism

Homo sapiens NCBITaxon:9606

Cell source

COL4A1 G755R symptomatic donor and COL4A2 G702D asymptomatic carrier; corrected isogenic clones and independent controls

Publication

PMID:37977146

Pathograph links

Increased Matrix Metalloproteinase Activity perturbs fidelity: moderate Provides drug perturbation of proteolytic matrix abnormalities.

Show evidence (1 reference)

PMID:37977146 SUPPORT DIRECT PRIMARY RESULT In Vitro

"inhibiting MMP activity partially rescues the ECM abnormalities and mural cell phenotypic changes."

Partial in-vitro response.

Endothelial Barrier Dysfunction partially recapitulates fidelity: moderate Tests mural-cell paracrine injury to endothelial junctions.

Show evidence (1 reference)

PMID:37977146 SUPPORT DIRECT PRIMARY RESULT In Vitro

"these mural cell defects exert a detrimental effect on endothelial cell tight junctions through paracrine actions."

Culture evidence with endothelial identity limitations.

Show evidence (1 reference)

PMID:37977146 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we developed a co-culture model of mural and endothelial cells using human induced pluripotent stem cells"

Model construction in the primary paper.

COL4A1 haploinsufficiency patient fibroblasts PRIMARY_CELL_CULTURE

Frameshift and splice-site variants are associated with nonsense-mediated transcript decay and reduced COL4A1 protein. These peripheral cells support quantitative deficiency but do not directly reconstruct cerebral vessels or establish all downstream signaling mechanisms.

Organism

Homo sapiens NCBITaxon:9606

Cell source

Primary skin fibroblasts from affected members of two COL4A1 families

Publication

PMID:23065703

Pathograph links

Pathogenic COL4A1 Variation partially recapitulates fidelity: moderate Distinguishes quantitative loss from mutant-protein retention.

Show evidence (1 reference)

PMID:23065703 SUPPORT DIRECT PRIMARY RESULT In Vitro

"nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs)"

Patient-derived transcript evidence.

Show evidence (1 reference)

PMID:23065703 SUPPORT DIRECT PRIMARY RESULT In Vitro

"a clear reduction of COL4A1 protein expression were demonstrated"

Patient fibroblast protein-expression result.

🐁

Animal Models

Col4a1 delta-exon-41 constitutive and conditional mice

Models developmental vascular abnormalities, porencephaly and recurrent hemorrhage. Endothelial/pericyte expression produces hemorrhage; genetic background and timing strongly modify severity. Postnatal mutant induction is not equivalent to adult gene deletion. Lens-restricted experiments show cataract and nonautonomous anterior-segment changes without detectable UPR.

Species

Mouse

Genotype

Heterozygous Col4a1 delta-exon-41; conditional Flex41 recombination in selected lineages

Publication

PMID:25753534

Pathograph links

Intracellular Collagen IV Retention partially recapitulates fidelity: moderate Conditional and strain comparisons implicate retention in hemorrhage susceptibility.

Show evidence (1 reference)

PMID:25753534 SUPPORT DIRECT PRIMARY RESULT Model Organism

"intracellular accumulation of mutant collagen in vascular endothelial cells and pericytes was a key triggering factor of ICH"

Mouse mechanistic comparisons.

Abnormal Cerebral Vascular Development partially recapitulates fidelity: moderate Embryonic vascular architecture differs from controls.

Show evidence (1 reference)

PMID:25753534 SUPPORT DIRECT PRIMARY RESULT Model Organism

"increased vessel density and tortuosity in Col4a1+/Δex41 hindbrains"

Embryonic anatomical result.

Abnormal Ocular Anterior Segment Development partially recapitulates fidelity: moderate Lens-restricted perturbation causes partial ocular disease.

Show evidence (1 reference)

PMID:28237965 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Mice with lens-specific expression of mutant Col4a1 had cataracts"

Cell-specific expression with ocular readouts.

Col4a1 G498V and G1064D cerebroretinal vascular models

Models focal arterial smooth-muscle loss and hypermuscularized transitional segments. Retinal preparations permit ex vivo contraction measurements, while intracerebral hemorrhage is measured in brain. Upstream-pressure effects are computational predictions. Notch3 dosage reduction decreases hypermuscularization and hemorrhage without correcting smooth-muscle loss.

Species

Mouse

Genotype

Heterozygous Col4a1 G498V or G1064D; G498V crossed with Notch3 heterozygous deletion

Publication

PMID:32183562

Pathograph links

Transitional Vessel Hypermuscularization perturbs fidelity: moderate Models excess transitional muscular coverage and its genetic suppression.

Show evidence (1 reference)

PMID:32183562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"genetic reduction of Notch3 in Col4a1+/G498V mice protected against ICH."

Genetic interaction in a defined mutant mouse.

Arteriolar Smooth Muscle Cell Loss partially recapitulates fidelity: moderate Anatomically separate arterial degeneration persists after Notch3 reduction.

Show evidence (1 reference)

PMID:32183562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"arteriolar SMC loss was unchanged in Col4a1+/G498V, Notch3+/- mice."

Null rescue result distinguishes vascular components.

Col4a1 G394V and G1344D age-dependent arterial dysfunction models

Both alleles develop reduced arterial myogenic tone with age, but G394V shows PIP2-dependent TRPM4 impairment whereas G1344D shows impaired SR calcium release. In G1344D, phenylbutyrate from birth preserves function; this is prevention rather than reversal of established adult disease.

Species

Mouse

Genotype

Heterozygous Col4a1 G394V or G1344D; comparisons at 3 and 12 months

Publication

PMID:37963192

Pathograph links

Impaired Cerebral Arterial Myogenic Tone partially recapitulates fidelity: moderate Models age-dependent arterial contractile dysfunction.

Show evidence (1 reference)

PMID:36693102 SUPPORT DIRECT PRIMARY RESULT In Vitro

"is blunted in cerebral arteries from middle-aged (12 mo old) but not young adult (3 mo old) animals"

G394V pressure-myography comparison. Readout obtained from isolated mutant-mouse vessels or cells.

Impaired Sarcoplasmic Reticulum Calcium Release partially recapitulates fidelity: moderate G1344D provides a distinct calcium-release mechanism.

Show evidence (1 reference)

PMID:37963192 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the release of SR Ca2+ from RyRs is impaired in the SMCs of Col4a1+/G1344D mice in an age-dependent manner."

Ex vivo primary-cell physiology in the mouse model.

Col4a1 multifunction fluorescent-tag and conditional-null mouse

Provides spatial and temporal measurements of postnatal cerebrovascular collagen turnover. Heterozygous deletion was less pathogenic than dominant missense alleles in mice, supporting investigation of allele suppression but not proving a safe human gene-therapy strategy. Human haploinsufficiency cases and species differences remain relevant.

Species

Mouse

Genotype

Dual-color Col4a1 tagged allele with conditional knockout potential

Publication

PMID:40279671

Pathograph links

Abnormal Extracellular Collagen IV Network perturbs fidelity: moderate Tests matrix turnover and quantitative loss, rather than a misfolded dominant protein.

Show evidence (1 reference)

PMID:40279671 SUPPORT DIRECT PRIMARY RESULT Model Organism

"heterozygous Col4a1 deletion is significantly less pathogenic than dominant Col4a1 missense mutations"

Relative mouse pathogenicity; not evidence that human COL4A1 loss is harmless.

Adult brain endothelial Col4a1 editing mouse

Adult microvascular Col4a1 depletion produces progressive microbleeds and basement-membrane thinning. Macroscopic hemorrhage and white-matter changes were absent in the reported study. This engineered adult loss model addresses matrix maintenance and does not reproduce germline dominant-negative collagen assembly.

Species

Mouse

Genotype

AAV-BR1 guide RNA delivery to adult Cas9-transgenic brain endothelium

Publication

PMID:42225261

Pathograph links

Cerebral Microvascular Fragility perturbs fidelity: moderate Tests adult endothelial matrix dependence with a microbleed endpoint.

Show evidence (1 reference)

PMID:42225261 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Histological examinations revealed haemosiderin deposits corresponding to MRI-detected CMBs, without macroscopic intracerebral haemorrhage or white matter changes."

Explicit fidelity limits from the study abstract.

col4a1 crispant and stable delta20 zebrafish

Crispants show spontaneous hemorrhage and abnormal vascular basement membranes. Stable delta20 larvae show vascular abnormalities and enhanced susceptibility to pharmacologically induced bleeding, whereas adults develop spontaneous brain hemorrhage. Increased mmp9 transcription and partial inhibitor rescue support mechanistic studies. A loss model does not establish dominance or variant-specific human fidelity.

Species

Zebrafish

Genotype

F0 col4a1 CRISPR knockdown and germline-transmissible 20-bp deletion

Publication

PMID:40846110

Pathograph links

Increased Matrix Metalloproteinase Activity perturbs fidelity: moderate Tests the contribution of mmp9 in a whole-animal loss model.

Show evidence (1 reference)

PMID:40846110 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Pharmacological inhibition of mmp9 was sufficient to ameliorate some cerebrovascular phenotypes."

Partial zebrafish rescue; drug efficacy in patients is not established.

col4a1 morphant and multiplex crispant zebrafish

Complementary loss models show ventriculomegaly, spontaneous/stress-induced hemorrhage, microphthalmia and lens abnormalities. Wild-type human RNA partially rescues several phenotypes; G755R and G773R rescue is phenotype-dependent and generally impaired. Full text shows partial G773R rescue of one lens-actin readout, so failure is not universal across assays. Developmental complementation is not a therapeutic trial or stand-alone clinical variant-classification rule.

Species

Zebrafish

Genotype

Morpholino knockdown and F0 CRISPR targeting exons 11, 19 and 30; human COL4A1 RNA complementation

Publication

PMID:41248836

Pathograph links

Abnormal Ocular Anterior Segment Development partially recapitulates fidelity: moderate Models selected ocular defects and allele-dependent developmental rescue.

Show evidence (1 reference)

PMID:41248836 SUPPORT DIRECT PRIMARY RESULT Model Organism

"while COL4A1G755R exacerbated the defect observed in col4a1 KD fish"

Full-text lens-actin assay distinguishes alleles and endpoints.

Col4a1 Raw and Svc renal models

Models glomerular/Bowman-capsule defects, hematuria, proteinuria, hypotension and tubular concentrating dysfunction. Chronic renal ER stress and apoptotic markers accompany medullary atrophy. This study did not detect renal cyst formation or tubular basement-membrane defects, and declining filtration did not continue across every age group. Mouse polyuria and diabetes-insipidus findings are not assigned as established human BSVD1 phenotypes.

Species

Mouse

Genotype

Heterozygous Col4a1 K950E (Raw) or G1064D (Svc)

Publication

PMID:26839400

Pathograph links

Renal Tubular Cell Loss partially recapitulates fidelity: moderate Models a tissue-specific intracellular-stress contribution to renal disease with important human-fidelity limits.

Show evidence (1 reference)

PMID:26839400 SUPPORT DIRECT PRIMARY RESULT Model Organism

"All 3- to 4-month-old Col4a1+/Raw mice also expressed cleaved caspase 3"

Renal apoptotic marker accompanies the chronic stress response; causality is supported by temporal association rather than selective pathway rescue.

{ }

Source YAML

click to show

name: Brain Small Vessel Disease 1 With Or Without Ocular Anomalies
category: Mendelian
creation_date: "2026-07-30T23:40:00Z"
synonyms:
- COL4A1-related brain small vessel disease
- Brain small vessel disease with hemorrhage
- Brain small vessel disease with Axenfeld-Rieger anomaly
- COL4A1 porencephaly
- Autosomal dominant porencephaly type 1
- BSVD1
description: >-
  Brain small vessel disease 1 with or without ocular anomalies (BSVD1) is an autosomal dominant COL4A1 disorder
  with cerebrovascular involvement ranging from prenatal hemorrhagic injury and porencephaly to adult small-vessel
  disease or clinically silent MRI abnormalities. Ocular, renal, muscular and other systemic manifestations
  overlap variably with the wider COL4A1 spectrum. COL4A1 encodes the alpha-1 chain of the alpha1-alpha1-alpha2
  type IV collagen heterotrimer. Pathogenic variants commonly alter triple-helical glycine residues, but splice,
  initiation-codon, truncating and other variants also occur. Intracellular retention, quantitative collagen
  deficiency, abnormal extracellular networks and altered vascular signaling contribute in variant- and tissue-dependent
  combinations. Clinical severity is highly variable within families. Hemorrhage can be spontaneous or modified
  by trauma, anticoagulant exposure and other vascular risks. Management is multidisciplinary surveillance,
  risk reduction and treatment of individual manifestations; mechanism-directed therapies remain experimental.
disease_term:
  preferred_term: brain small vessel disease 1 with or without ocular anomalies
  term:
    id: MONDO:0008289
    label: brain small vessel disease 1 with or without ocular anomalies
parents:
- COL4A1-related disorder
- Hereditary cerebral small vessel disease
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0008289
      label: brain small vessel disease 1 with or without ocular anomalies
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      MONDO:0008289 is the exact disease concept — an autosomal dominant familial
      porencephaly / brain small-vessel disease caused by mutation in COL4A1,
      variably associated with ocular anomalies (OMIM:175780).
references:
- reference: PMID:15905400
  title: "Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly."
- reference: PMID:16107487
  title: "Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly."
- reference: PMID:16598045
  title: "Role of COL4A1 in small-vessel disease and hemorrhagic stroke."
- reference: PMID:17696175
  title: "COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke."
- reference: PMID:18160688
  title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
- reference: PMID:20301768
  title: COL4A1-Related Disorders.
  tags:
  - GeneReviews
- reference: PMID:20558831
  title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
- reference: PMID:23065703
  title: Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.
- reference: PMID:24001601
  title: Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.
- reference: PMID:24374867
  title: "Fetal intracerebral hemorrhage and cataract: think COL4A1."
- reference: PMID:25719457
  title: "The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature."
- reference: PMID:25753534
  title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
- reference: PMID:26839400
  title: ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.
- reference: PMID:27794444
  title: "Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations."
- reference: PMID:28237965
  title: Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse.
- reference: PMID:29895609
  title: Use of sodium 4-phenylbutyrate to define therapeutic parameters for reducing intracerebral hemorrhage and myopathy in Col4a1 mutant mice.
- reference: PMID:30351356
  title: 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease.
- reference: PMID:31051113
  title: COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
- reference: PMID:32183562
  title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
- reference: PMID:34424299
  title: Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome.
- reference: PMID:35525525
  title: Elevated TGFβ signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice.
- reference: PMID:36435425
  title: Elevated TGFβ signaling contributes to cerebral small vessel disease in mouse models of Gould syndrome.
- reference: PMID:36693102
  title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
- reference: PMID:37963192
  title: Impaired intracellular Ca(2+) signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice.
- reference: PMID:37977146
  title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
- reference: PMID:39016117
  title: Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol.
- reference: PMID:40279671
  title: A multifunction murine Col4a1 allele reveals potential gene therapy parameters for Gould syndrome.
- reference: PMID:40846110
  title: Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease.
- reference: PMID:41248836
  title: Zebrafish col4a1 loss-of-function models mirror key neurovascular and ocular features of COL4A1/A2 syndrome and enable human variants assessment in vivo.
- reference: PMID:42099677
  title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
- reference: PMID:42225261
  title: A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels.
- reference: PMID:42605108
  title: "Perinatal complications, mode of delivery, and neurological morbidity in children with COL4A1/A2 variants."
- reference: clinicaltrials:NCT01097564
  title: "COL4A1 Gene Related Cerebra-retinal Angiopathy : Clinical Spectrum From Children to Adult, Mutational Spectrum and Application to Routine Management of Affected Patients : a Prospective Cohort Study"
- reference: clinicaltrials:NCT07374913
  title: Study of the Familial Phenotype Associated With Mutations in the COL4A1 and COL4A2 Genes
- reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
  title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
- reference: url:https://eprints.gla.ac.uk/309664/1/309664.pdf
  title: "https://eprints.gla.ac.uk/309664/1/309664.pdf"
- reference: url:https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6360271/fullTextXML
  title: Abstract
- reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
  title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
- reference: PMID:40616396
  title: "COL4A1 and COL4A2-related disorders: Clinical features, diagnostic guidelines, and management."
  findings: []
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    Autosomal dominant inheritance with a 50% transmission risk for each child of a heterozygous individual.
    Inherited and de novo variants both occur. The GeneReviews estimate of at least 27% de novo cases reflects
    historically ascertained families rather than a fixed population rate. Clinical expression is highly variable;
    an asymptomatic carrier with abnormal brain MRI still has a detectable manifestation. Overall penetrance
    is not precisely established across variants, ages and organs.
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "COL4A1-related disorders are inherited in an autosomal dominant manner."
    explanation: GeneReviews establishes autosomal dominant inheritance.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The proportion of cases caused by a de novo pathogenic variant is estimated to be at least 27%."
    explanation: Quantifies the de novo fraction.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:16107487
    reference_title: "Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The last mutation was also present in an asymptomatic obligate carrier with white matter abnormalities on brain magnetic resonance imaging."
    explanation: Clinically asymptomatic carriage with an MRI abnormality demonstrates variable expression; it does not by itself prove complete nonpenetrance.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Each child of an individual with a COL4A1-related disorder has a 50% chance of inheriting the pathogenic variant.
    explanation: Mendelian transmission risk, distinct from predicting severity.
    quote_role: REVIEW_SYNTHESIS
genetic:
- name: COL4A1
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  gene_term:
    preferred_term: COL4A1
    term:
      id: hgnc:2202
      label: COL4A1
  notes: >-
    Most described pathogenic variants are triple-helical glycine substitutions; the 2016 review enumerated
    68 glycine-substitution occurrences among 93 reported COL4A1 mutation occurrences, not a universal 90%
    fraction. Initiation-codon, splice, frameshift, nonsense and other variants occur. Two families with COL4A1
    haploinsufficiency had aberrant transcripts and reduced protein. HANAC-associated variants cluster around
    residues Gly498-Gly528 in exons 24-25, but position is not a deterministic clinical predictor. COL4A2-related
    BSVD2 is a distinct, overlapping disorder. COL4A1 overexpression due to 3-prime UTR variants in PADMAL
    or COL4A1/COL4A2 copy-number gains has a distinct dosage mechanism and is not equated with this entry.
  evidence:
  - reference: PMID:27794444
    reference_title: "Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "glycine (Gly) substitutions within the triple helical domain are the most common class of mutations."
    explanation: Establishes glycine substitutions in the triple helix as the dominant variant class.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:18160688
    reference_title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified three closely located glycine mutations in exons 24 and 25 of the gene COL4A1, which encodes procollagen type IV alpha1."
    explanation: Localizes the HANAC-associated variants to exons 24-25.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
  - reference: PMID:25719457
    reference_title: "The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Since 2005, COL4A1 mutations have been known as an autosomal dominant cause of hereditary porencephaly."
    explanation: Establishes COL4A1 as the causative autosomal dominant gene.
    directness: DIRECT
    quote_role: BACKGROUND
  - reference: PMID:23065703
    reference_title: Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs) and a clear reduction of COL4A1 protein expression were demonstrated
    explanation: Patient fibroblast findings support quantitative deficiency in two families.
    quote_role: PRIMARY_RESULT
- name: FN1 candidate modifier
  relationship_type: MODIFIER
  notes: The murine MoGS1 locus contains 18 protein-coding genes including Fn1. Increased Fn1 expression and altered integrin signaling nominate it as a candidate modifier of ocular dysgenesis and myopathy. The interval did not suppress intracerebral hemorrhage. This is neither a demonstrated human modifier nor single-gene causal resolution of the interval.
  evidence:
  - reference: PMID:34424299
    reference_title: Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: Of the four positional candidate genes that were differentially expressed, Fn1 is a strong functional candidate.
    explanation: Expression and functional considerations nominate Fn1 within the mouse modifier interval; single-gene causality and human modification remain unproven.
    quote_role: PRIMARY_RESULT
  - reference: PMID:34424299
    reference_title: Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: MoGS1 had no effect on ICH
    explanation: Counterevidence to modification of intracerebral hemorrhage by the interval; it does not refute ocular or muscle modification or establish which gene drives it.
    quote_role: PRIMARY_RESULT
  gene_term:
    preferred_term: FN1
    term:
      id: hgnc:3778
      label: FN1
pathophysiology:
- name: Pathogenic COL4A1 Variation
  biological_scale: MOLECULAR
  description: Heterozygous germline COL4A1 variants perturb alpha1-alpha1-alpha2 collagen IV production or function. Glycine substitutions and in-frame splice defects can compromise heterotrimers, whereas some truncating or splice variants reduce transcript and protein abundance. These alternatives are not assumed to act identically.
  evidence:
  - reference: PMID:16107487
    reference_title: Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: There were two missense mutations of glycine residues predicted to result in abnormal collagen IV assembly, and one mutation predicted to abolish the traditional COL4A1 start codon.
    explanation: Human families establish variant heterogeneity; assembly effects were predicted.
    quote_role: PRIMARY_RESULT
  - reference: PMID:23065703
    reference_title: Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs) and a clear reduction of COL4A1 protein expression were demonstrated
    explanation: Patient fibroblast protein reduction supports the quantitative-deficiency arm.
    quote_role: PRIMARY_RESULT
  genes:
  - preferred_term: COL4A1
    term:
      id: hgnc:2202
      label: COL4A1
  downstream:
  - target: Intracellular Collagen IV Retention
    description: Misfolded collagen accumulates intracellularly for secretion-impaired variants.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id001
      reference: PMID:15905400
      reference_title: Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: inhibits the secretion of mutant and normal type IV collagen.
      explanation: Dominant mutant mouse allele affects secretion of coassembled collagen.
      quote_role: PRIMARY_RESULT
  - target: Abnormal Extracellular Collagen IV Network
    description: Variant-dependent quantitative and qualitative defects affect the extracellular network.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id002
      reference: PMID:18160688
      reference_title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: Histologic analysis revealed complex basement-membrane defects in kidney and skin.
      explanation: Direct human ultrastructural findings; organ-specific effects vary.
      quote_role: PRIMARY_RESULT
  - target: Abnormal Ocular Anterior Segment Development
    description: Conditional lens expression of mutant Col4a1 causes ocular dysgenesis.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id012
      reference: PMID:28237965
      reference_title: Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: Mice with lens-specific expression of mutant Col4a1 had cataracts
      explanation: Conditional mouse expression separates lens pathology from broader vascular injury.
      quote_role: PRIMARY_RESULT
  molecular_functions:
  - preferred_term: extracellular matrix structural constituent
    term:
      id: GO:0005201
      label: extracellular matrix structural constituent
    modifier: ABNORMAL
- name: Intracellular Collagen IV Retention
  biological_scale: CELLULAR
  description: Mutant and coassembled collagen IV can accumulate in the endoplasmic reticulum at the expense of secretion. Severity varies with allele and cell type. In the delta-exon-41 mouse, reducing intracellular accumulation protected against hemorrhage without necessarily restoring extracellular abundance or vascular branching.
  evidence:
  - *id001
  - reference: PMID:25753534
    reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: intracellular accumulation of mutant collagen in vascular endothelial cells and pericytes was a key triggering factor of ICH
    explanation: Mouse genetic and pharmacologic comparisons implicate retention without proving a universal ER-stress cascade.
    quote_role: PRIMARY_RESULT
  cell_types:
  - preferred_term: endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  - preferred_term: pericyte
    term:
      id: CL:0000669
      label: pericyte
  downstream:
  - target: Endoplasmic Reticulum Stress
    description: Retention can elicit a stress response in susceptible tissues and variants.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:24001601
      reference_title: Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: INDIRECT
      snippet: This intracellular accumulation led to ER stress, unfolded protein response activation, reduced cell proliferation and increased apoptosis.
      explanation: Comparative COL4A2 G702D fibroblast evidence is indirect for COL4A1.
      quote_role: PRIMARY_RESULT
  - target: Abnormal Extracellular Collagen IV Network
    description: Impaired export can reduce basement-membrane collagen deposition.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id001
  - target: Cerebral Microvascular Fragility
    description: Reducing retention diminishes hemorrhagic susceptibility in a mouse model; intervening events are incompletely resolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25753534
      reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: intracellular accumulation of mutant collagen in vascular endothelial cells and pericytes was a key triggering factor of ICH
      explanation: Conditional cellular localization and rescue in mice.
      quote_role: PRIMARY_RESULT
- name: Endoplasmic Reticulum Stress
  biological_scale: CELLULAR
  description: Unfolded-protein responses occur in selected collagen IV cellular and animal models, but intracellular retention does not invariably activate measurable ER stress. The COL4A2 G702D fibroblast study is comparative evidence, not direct proof in COL4A1 cerebral endothelium. Col4a1 mutant lenses accumulated collagen without detectable UPR activation. ER stress therefore cannot be assigned as the obligatory link to all vascular or ocular disease.
  evidence:
  - reference: PMID:24001601
    reference_title: Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: INDIRECT
    snippet: This intracellular accumulation led to ER stress, unfolded protein response activation, reduced cell proliferation and increased apoptosis.
    explanation: Patient COL4A2 fibroblasts; indirect relevance to this COL4A1 entry.
    quote_role: PRIMARY_RESULT
  - reference: PMID:28237965
    reference_title: Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: we did not detect evidence of UPR activation
    explanation: Negative lens result limits a universal retention-to-UPR mechanism.
    quote_role: PRIMARY_RESULT
  - reference: PMID:26839400
    reference_title: ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: medullary atrophy was associated with chronic ER stress
    explanation: Direct COL4A1 mouse renal evidence complements comparative COL4A2 fibroblast findings.
    quote_role: PRIMARY_RESULT
  biological_processes:
  - preferred_term: response to endoplasmic reticulum stress
    term:
      id: GO:0034976
      label: response to endoplasmic reticulum stress
    modifier: INCREASED
  downstream:
  - target: Impaired Sarcoplasmic Reticulum Calcium Release
    description: In the G1344D mouse, ER/SR dysfunction is proposed to impair calcium release; causation is not established across alleles.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:37963192
      reference_title: Impaired intracellular Ca(2+) signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: the release of SR Ca2+ from RyRs is impaired in the SMCs of Col4a1+/G1344D mice in an age-dependent manner.
      explanation: Smooth-muscle calcium-release results in a retention-prone allele. Readout obtained from isolated mutant-mouse vessels or cells.
      quote_role: PRIMARY_RESULT
  - target: Renal Tubular Cell Loss
    description: Chronic renal ER stress is proposed to promote tubular cell loss; stress and apoptosis precede or accompany medullary atrophy.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id014
      reference: PMID:26839400
      reference_title: ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: All 3- to 4-month-old Col4a1+/Raw mice also expressed cleaved caspase 3
      explanation: Renal apoptotic marker accompanies the chronic stress response; causality is supported by temporal association rather than selective pathway rescue.
      quote_role: PRIMARY_RESULT
- name: Abnormal Extracellular Collagen IV Network
  biological_scale: TISSUE
  description: Collagen IV abundance, assembly and network quality may be altered independently. Human kidney and skin show thickening, duplication and disorganization; mouse vessels can show focal discontinuities. Increasing secretion need not restore mechanical stability if mutant collagen enters the matrix.
  evidence:
  - *id002
  - reference: PMID:30351356
    reference_title: 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: the persistence of defects in BM structure and reduced ability of the BM to withstand mechanical stress
    explanation: Chaperone-treated mutant mice retain abnormal basement-membrane structure.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Increased TGF-beta Signaling
    description: Altered matrix regulation is a candidate upstream explanation for increased TGF-beta activity; ligand availability was not directly established.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:36693102
      reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
      supports: NO_EVIDENCE
      evidence_source: OTHER
      directness: INDIRECT
      snippet: It is also not known how COL4A1 mutations increase TGF-β signaling.
      explanation: Discussion explicitly identifies an unresolved upstream mechanism; this sentence does not provide experimental support for a matrix-to-TGF-beta causal link.
      quote_role: BACKGROUND
  - target: Increased NOTCH3 Signaling
    description: Reduced extracellular collagen in transitional segments may release restraint on NOTCH3, but the molecular link remains uncertain.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id003
      reference: PMID:32183562
      reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: 7 out of 11 of these Notch3 target genes were upregulated in brain microvessels
      explanation: Mouse microvessels enriched for transitional segments; not uniform upregulation in arteries.
      quote_role: PRIMARY_RESULT
  - target: Increased Matrix Metalloproteinase Activity
    description: Mural-cell matrix defects accompany differentiation-dependent metalloproteinase dysregulation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id008
      reference: PMID:37977146
      reference_title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: COL4A1/A2 models also express high levels of matrix metalloproteinases (MMPs)
      explanation: Human iPSC-derived mural cultures; expression differs by enzyme and differentiation stage.
      quote_role: PRIMARY_RESULT
  - target: Cerebral Microvascular Fragility
    description: Loss of vascular basement-membrane integrity contributes to bleeding susceptibility.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id010
      reference: PMID:15905400
      reference_title: Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: porencephaly secondary to focal disruptions of vascular basement membranes.
      explanation: Founding mouse model establishes a vascular structural lesion.
      quote_role: PRIMARY_RESULT
  - target: Renal Basement Membrane Abnormality
    description: Systemic collagen defects involve renal basement membranes.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id002
  - target: Skeletal Muscle Basement Membrane Dysfunction
    description: Muscle matrix dysfunction contributes to myopathy, with variant-dependent extracellular toxicity.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id013
      reference: PMID:31051113
      reference_title: COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: independent muscular, neural, and vascular insults contribute to neuromyopathy
      explanation: Separate contributions demonstrated in conditional mouse models.
      quote_role: PRIMARY_RESULT
  - target: Abnormal Cerebral Vascular Development
    description: Extracellular dysfunction is proposed to perturb vascular patterning independently of retention burden.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25753534
      reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: abnormal angiogenesis is independent from the level of intracellular collagen accumulation
      explanation: Mouse allele/background comparisons support distinct processes.
      quote_role: PRIMARY_RESULT
- name: Abnormal Cerebral Vascular Development
  biological_scale: TISSUE
  description: Embryonic Col4a1 delta-exon-41 mice develop excessive, tortuous cerebral vessels. Vascular patterning defects can persist when interventions reduce intracellular collagen accumulation and hemorrhage. Early developmental requirements do not imply that adult collagen maintenance is dispensable.
  evidence:
  - reference: PMID:25753534
    reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: increased vessel density and tortuosity in Col4a1+/Δex41 hindbrains
    explanation: Embryonic vascular-development result.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Cerebral Microvascular Fragility
    description: Abnormal vascular development contributes to the substrate for later hemorrhage in this allele.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25753534
      reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: Col4a1 and Col4a2 mutations cause abnormal angiogenesis.
      explanation: Developmental model finding.
      quote_role: PRIMARY_RESULT
- name: Increased TGF-beta Signaling
  biological_scale: CELLULAR
  description: TGF-beta target-gene and reporter activity are increased in Col4a1 mutant models. Reduced Tgfb1 dosage improves several vascular and hemorrhagic outcomes, but not every challenge or developmental abnormality. Whole-brain phospho-SMAD measurements were not uniformly significant. This signaling branch is supported preclinically and is not equated with a demonstrated TGF-beta-to-NOTCH3 cascade.
  evidence:
  - reference: PMID:36435425
    reference_title: Elevated TGFβ signaling contributes to cerebral small vessel disease in mouse models of Gould syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: Tgfb1 heterozygosity significantly reduced ICH severity in P7 and 1MO Col4a1+/G1344D mice
    explanation: Genetic perturbation in Col4a1 mutant mice supports a pathogenic contribution of TGF-beta signaling.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Arteriolar Smooth Muscle Cell Loss
    description: Reduced Tgfb1 dosage preserves mural coverage in mutant mice, implicating signaling in degeneration.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:36435425
      reference_title: Elevated TGFβ signaling contributes to cerebral small vessel disease in mouse models of Gould syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: Tgfb1 heterozygosity protected Col4a1+/G1344D mice from age-related arteriolar VSMC loss even when aged up to 8MO
      explanation: Direct mural-coverage comparison, rather than hemorrhage alone.
      quote_role: PRIMARY_RESULT
  - target: Reduced Smooth Muscle PIP2 Availability
    description: TGF-beta receptor and PI3K inhibitor rescue supports a TGF-beta–PI3K–PIP2 pathway in aged G394V arteries.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:36693102
      reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: Acute inhibition of PI3K activity and blockade of transforming growth factor-beta (TGF-β) receptors also rescued the myogenic response
      explanation: Pharmacologic pathway inference in isolated mouse arteries. Readout obtained from isolated mutant-mouse vessels or cells.
      quote_role: PRIMARY_RESULT
    intermediate_mechanisms:
    - Increased PI3K-dependent conversion of PIP2 to PIP3
  - target: Abnormal Ocular Anterior Segment Development
    description: Reducing TGF-beta signaling partially rescues ocular development in mutant mice.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35525525
      reference_title: Elevated TGFβ signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: genetically reducing TGFβ signaling partially prevented ASD.
      explanation: Mouse ocular genetic interaction.
      quote_role: PRIMARY_RESULT
- name: Increased NOTCH3 Signaling
  biological_scale: CELLULAR
  description: NOTCH3 target-gene activation is enriched in transitional microvessels of Col4a1 G498V mice. Reducing Notch3 dosage attenuates transitional muscularization and hemorrhage, while arteriolar smooth-muscle loss persists.
  evidence:
  - *id003
  downstream:
  - target: Transitional Vessel Hypermuscularization
    description: Notch3 genetic reduction suppresses excess transitional mural-cell number and contractile-protein expression.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32183562
      reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: it strikingly significantly attenuated α-SMA expression and mural cell number in TS
      explanation: Genetic interaction supports NOTCH3 involvement.
      quote_role: PRIMARY_RESULT
- name: Transitional Vessel Hypermuscularization
  biological_scale: TISSUE
  description: Transiently increased mural-cell proliferation produces excess muscular coverage of the arteriole-capillary transition in G498V and G1064D mice. Ex vivo retinal transitional segments show increased tone and contraction. Increased upstream pressure is a computational prediction; it was not directly measured in vivo.
  evidence:
  - reference: PMID:32183562
    reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: this TS was hypermuscularized, with a hyperplasia of mural cells expressing more contractile proteins
    explanation: Distinct mural-cell population at the arteriole-capillary transition in mutant mice.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Cerebral Microvascular Fragility
    description: Excess downstream resistance is predicted to raise pressure in upstream arteries weakened by smooth-muscle loss.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32183562
      reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      directness: DIRECT
      snippet: pressure drop was reduced resulting in higher intravascular pressure in middle-size arterioles
      explanation: Computational retinal-network model, not a direct pressure measurement.
      quote_role: PRIMARY_RESULT
    intermediate_mechanisms:
    - Increased transitional vascular resistance
    - Predicted elevation of upstream mean and pulse pressure
- name: Arteriolar Smooth Muscle Cell Loss
  biological_scale: CELLULAR
  description: Focal and segmental arteriolar smooth-muscle loss weakens arteries in mouse models. Its persistence despite protective Notch3 reduction shows that smooth-muscle loss alone is insufficient to explain all hemorrhage risk.
  evidence:
  - &id004
    reference: PMID:32183562
    reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: whereas the upstream arteriole exhibited a loss of SMCs.
    explanation: Anatomically distinct arterial smooth-muscle loss accompanies transitional hypermuscularization.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Cerebral Microvascular Fragility
    description: Loss of mural support contributes to wall vulnerability together with other vascular defects.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id004
- name: Reduced Smooth Muscle PIP2 Availability
  biological_scale: MOLECULAR
  description: Reduced PIP2 availability is inferred from lipid-dialysis and PI3K-blockade rescue in 12-month-old G394V smooth-muscle cells. ATP levels were unchanged. This mechanism differs from the G1344D calcium-release defect and should not be generalized to every COL4A1 variant.
  evidence:
  - reference: PMID:36693102
    reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: Dialyzing SMCs with PIP2 and selective blockade of phosphoinositide 3-kinase (PI3K)
    explanation: Pharmacologic and lipid-dialysis rescue supports reduced PIP2 availability; depletion was inferred rather than directly quantified. Readout obtained from isolated mutant-mouse vessels or cells.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Reduced TRPM4 Channel Activity
    description: Reduced availability of the PIP2 cofactor diminishes channel activity.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:36693102
      reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: whole-cell TRPM4 currents ... were restored to the levels recorded from age-matched Col4a1+/+ mice.
      explanation: Exogenous PIP2 restored whole-cell TRPM4 currents in isolated mutant-mouse arterial smooth-muscle cells.
      quote_role: PRIMARY_RESULT
- name: Impaired Sarcoplasmic Reticulum Calcium Release
  biological_scale: CELLULAR
  description: In aged G1344D mice, vascular smooth-muscle calcium sparks and evoked sarcoplasmic-reticulum release are reduced. Reduced store content is inferred, not directly measured. TRPM4 currents elicited with high intracellular calcium remain intact, favoring impaired activation over loss of channels.
  evidence:
  - &id005
    reference: PMID:37963192
    reference_title: Impaired intracellular Ca(2+) signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: the release of SR Ca2+ from RyRs is impaired in the SMCs of Col4a1+/G1344D mice in an age-dependent manner.
    explanation: Mouse vascular smooth-muscle calcium-release finding; the size of the store is inferred. Readout obtained from isolated mutant-mouse vessels or cells.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Reduced TRPM4 Channel Activity
    description: Reduced calcium delivery limits calcium-dependent TRPM4 activation in the G1344D model.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id005
- name: Reduced TRPM4 Channel Activity
  biological_scale: MOLECULAR
  description: Depolarizing monovalent-cation currents through TRPM4 are reduced in selected aged Col4a1 mutant arterial smooth-muscle cells. G394V PIP2-dependent dysfunction and G1344D calcium-release-dependent dysfunction are distinct upstream routes. TRPM4 itself is not calcium-permeable.
  evidence:
  - &id006
    reference: PMID:36693102
    reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: a significant decrease in depolarizing cation currents conducted by TRPM4
    explanation: Direct electrophysiology in 12-month-old Col4a1 G394V arterial smooth muscle. Readout obtained from isolated mutant-mouse vessels or cells.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Impaired Cerebral Arterial Myogenic Tone
    description: Loss of depolarizing current reduces voltage-dependent calcium entry and pressure-induced contraction.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - *id006
    intermediate_mechanisms:
    - Reduced smooth-muscle depolarization
    - Reduced voltage-dependent calcium entry
- name: Impaired Cerebral Arterial Myogenic Tone
  biological_scale: TISSUE
  description: Pressure-induced constriction is reduced in aged mutant cerebral arteries despite preserved passive diameter and high-potassium contraction. This impairs a component of autoregulation. It is anatomically and experimentally distinct from increased contraction of transitional segments in other alleles.
  evidence:
  - &id007
    reference: PMID:36693102
    reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: is blunted in cerebral arteries from middle-aged (12 mo old) but not young adult (3 mo old) animals
    explanation: Age-dependent pressure myography result in Col4a1 G394V mice. Readout obtained from isolated mutant-mouse vessels or cells.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Cerebral Microvascular Fragility
    description: Impaired autoregulation may expose downstream vessels to perfusion-pressure fluctuations; its precise contribution to human hemorrhage remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id007
- name: Increased Matrix Metalloproteinase Activity
  biological_scale: MOLECULAR
  description: Patient-derived COL4A1 G755R and comparative COL4A2 G702D mural-cell models have dysregulated MMP expression/activity. MMP2 is reduced early and elevated after maturation; MMP9 is increased later and MMP7 earlier. Pharmacologic inhibition partially rescues matrix and cellular abnormalities. Zebrafish col4a1 loss also increases mmp9 transcription.
  evidence:
  - *id008
  - reference: PMID:40846110
    reference_title: Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: elevated matrix metalloproteinase 9 (mmp9) transcription associated with loss of col4a1.
    explanation: Transcript finding in a zebrafish loss-of-function model, not direct enzyme activity in patients.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Endothelial Barrier Dysfunction
    description: Mural-cell paracrine effects and inhibitor rescue implicate metalloproteinases in endothelial-junction dysfunction.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id009
      reference: PMID:37977146
      reference_title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: these mural cell defects exert a detrimental effect on endothelial cell tight junctions through paracrine actions.
      explanation: Co-culture and conditioned-medium evidence, with limitations in the endothelial differentiation protocols.
      quote_role: PRIMARY_RESULT
- name: Endothelial Barrier Dysfunction
  biological_scale: CELLULAR
  description: 'Mutant human iPSC-derived mural cells disrupt endothelial junctions and barrier measurements in culture. Brain-endothelial-like cells in this protocol have epithelial identity limitations; validation in generic endothelial cells supports junction effects but lacks full BBB function. This is context-dependent: tracer studies in the earlier delta-exon-41 mouse did not detect a generalized barrier defect.'
  evidence:
  - *id009
  - reference: PMID:25753534
    reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: Cerebral and retinal vessels were not permeable to biotin, Evans blue dye or sodium fluorescein and tight junction proteins were normally expressed during brain development
    explanation: The full tracer experiments found retained barrier integrity despite hemorrhagic susceptibility.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Cerebral Microvascular Fragility
    description: Mural–endothelial dysfunction is a candidate additional contributor to microvascular vulnerability, with in-vivo applicability still under study.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id009
- name: Cerebral Microvascular Fragility
  biological_scale: TISSUE
  description: Defective basement membranes, mural-cell support and vascular regulation create susceptibility to cerebral vessel disruption. The relative contributions depend on allele, developmental stage and vessel segment. A separate adult endothelial Col4a1-depletion model produces microbleeds without macrohemorrhage or white-matter lesions.
  evidence:
  - *id010
  - reference: PMID:42225261
    reference_title: A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: significant basement membrane thinning in Col4a1-depleted microvessels.
    explanation: Adult targeted-deletion model supports a maintenance role, without reproducing the germline missense mechanism.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Cerebral Hemorrhagic Injury
    description: Vulnerable cerebral microvessels can bleed spontaneously or after additional stress.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id011
      reference: PMID:16598045
      reference_title: Role of COL4A1 in small-vessel disease and hemorrhagic stroke.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: predisposes both newborn and adult mice to intracerebral hemorrhage.
      explanation: Mouse hemorrhage phenotype at multiple ages.
      quote_role: PRIMARY_RESULT
- name: Cerebral Hemorrhagic Injury
  biological_scale: TISSUE
  description: Cerebral bleeding ranges from prenatal parenchymal injury and microhemorrhage to recurrent symptomatic intracerebral hemorrhage. Resorption of early destructive injury can leave porencephalic cavities. Hemorrhage is not required to explain every white-matter or systemic feature.
  evidence:
  - *id011
  downstream:
  - target: Intracerebral hemorrhage
    description: Clinical expression of parenchymal bleeding.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20558831
      reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: in 6 cases it was attributable to subcortical hemorrhage
      explanation: Human cohort observation.
      quote_role: REVIEW_SYNTHESIS
  - target: Cerebral microbleeds
    description: Small hemorrhagic deposits are detectable by MRI.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301768
      reference_title: COL4A1-Related Disorders.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages.
      explanation: GeneReviews imaging spectrum.
      quote_role: REVIEW_SYNTHESIS
  - target: Porencephaly
    description: Destructive prenatal/perinatal hemorrhage can evolve into a cystic cavity.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - *id010
    intermediate_mechanisms:
    - Loss and resorption of injured cerebral tissue
  - target: Infantile hemiparesis
    description: Early destructive brain injury can contribute to this manifestation; other mechanisms and variable severity remain possible.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301768
      reference_title: COL4A1-Related Disorders.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability
      explanation: Clinical injury-associated pattern; the exact causal intermediates are inferred.
      quote_role: REVIEW_SYNTHESIS
  - target: Seizures
    description: Early destructive brain injury can contribute to this manifestation; other mechanisms and variable severity remain possible.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301768
      reference_title: COL4A1-Related Disorders.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability
      explanation: Clinical injury-associated pattern; the exact causal intermediates are inferred.
      quote_role: REVIEW_SYNTHESIS
  - target: Intellectual disability
    description: Early destructive brain injury can contribute to this manifestation; other mechanisms and variable severity remain possible.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301768
      reference_title: COL4A1-Related Disorders.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability
      explanation: Clinical injury-associated pattern; the exact causal intermediates are inferred.
      quote_role: REVIEW_SYNTHESIS
- name: Abnormal Ocular Anterior Segment Development
  biological_scale: TISSUE
  description: Conditional lens expression of mutant Col4a1 causes cataract and dose-dependent abnormalities in adjacent anterior structures. Lens-autonomous and nonautonomous effects coexist; direct UPR activation was not detected in the studied lenses. Human anterior-segment dysgenesis includes Axenfeld-Rieger-type findings and may accompany glaucoma.
  evidence:
  - *id012
  - reference: PMID:17696175
    reference_title: COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Diffuse leukoencephalopathy associated with ocular malformations of the Axenfeld-Rieger type was observed in five individuals.
    explanation: Human clinical association.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Axenfeld-Rieger anomaly
    description: COL4A1 ocular dysgenesis includes this clinical pattern.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:17696175
      reference_title: COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: We delineate a novel association between the Axenfeld-Rieger anomaly and leukoencephalopathy and stroke.
      explanation: Family-level association; not proof of a specific developmental intermediate.
      quote_role: PRIMARY_RESULT
  - target: Cataract
    description: Lens pathology produces developmental cataract.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id012
- name: Renal Basement Membrane Abnormality
  biological_scale: TISSUE
  description: Human COL4A1 renal disease includes basement-membrane thickening and disorganization in tubules, Bowman capsule and interstitial capillaries. The anatomic evidence does not justify assigning all hematuria specifically to glomerular basement-membrane disruption.
  evidence:
  - *id002
  downstream:
  - target: Hematuria
    description: Hematuria accompanies the renal basement-membrane phenotype; the exact bleeding site is not established.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:18160688
      reference_title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: The clinical renal manifestations of the HANAC syndrome in these families include hematuria and bilateral, large cysts.
      explanation: Human renal manifestations.
      quote_role: PRIMARY_RESULT
  - target: Renal cysts
    description: Cystic disease is part of the renal phenotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:18160688
      reference_title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: hematuria and bilateral, large cysts.
      explanation: Observed human renal involvement.
      quote_role: PRIMARY_RESULT
- name: Skeletal Muscle Basement Membrane Dysfunction
  biological_scale: TISSUE
  description: Muscular, vascular and peripheral-nerve contributions to neuromyopathy can be separated in conditional mice. Extracellular mutant collagen may damage muscle even when increasing secretion benefits peripheral myelination. These experiments do not establish one uniform mechanism for human cramps.
  evidence:
  - *id013
  downstream:
  - target: Muscle cramps
    description: Muscle disease is a plausible contributor to cramps; the precise human mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301768
      reference_title: COL4A1-Related Disorders.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia)
      explanation: Clinical association; mechanism inferred from model findings.
      quote_role: REVIEW_SYNTHESIS
- name: Renal Tubular Cell Loss
  biological_scale: CELLULAR
  description: Col4a1 Raw/Svc mice develop renal stress-marker activation and apoptotic signals associated with medullary atrophy and impaired urinary concentration. In this study tubular basement membranes appeared structurally preserved, distinguishing this compartment from Bowman-capsule and glomerular matrix defects. The mouse findings do not establish universal diabetes insipidus or progressive renal failure in human BSVD1.
  evidence:
  - *id014
phenotypes:
- category: Neurological
  name: Porencephaly
  description: >-
    Fluid-filled cavities in the brain, typically the resorbed sequelae of
    perinatal cerebral hemorrhage, and the hallmark severe-end phenotype. Clinically
    manifests as infantile hemiparesis, seizures, and intellectual disability,
    though it can occasionally be an incidental finding.
  phenotype_term:
    preferred_term: Porencephaly
    term:
      id: HP:0002132
      label: Porencephalic cyst
  evidence:
  - reference: PMID:16107487
    reference_title: "Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This observation confirms COL4A1 as a major locus for genetic predisposition to perinatal cerebral haemorrhage and porencephaly"
    explanation: Confirms COL4A1 as a major cause of hereditary porencephaly.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
  - reference: PMID:15905400
    reference_title: "Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "approximately 18% of survivors had porencephaly."
    explanation: Recapitulation of porencephaly in the Col4a1 mouse model.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- category: Neurological
  name: Intracerebral hemorrhage
  description: >-
    Antenatal, perinatal or later-life intracerebral hemorrhage can be spontaneous or associated with trauma,
    exertion or anticoagulation. In the selected 2010 review of 52 COL4A1 carriers, six had symptomatic subcortical
    hemorrhagic stroke; the total of nine strokes also included three lacunar ischemic strokes. These counts
    do not establish a population frequency.
  phenotype_term:
    preferred_term: Cerebral hemorrhage
    term:
      id: HP:0001342
      label: Cerebral hemorrhage
  evidence:
  - reference: PMID:16598045
    reference_title: "Role of COL4A1 in small-vessel disease and hemorrhagic stroke."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "predisposes both newborn and adult mice to intracerebral hemorrhage."
    explanation: Establishes hemorrhage predisposition across ages.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A history of stroke was reported in 9 subjects (17.3%); in 6 cases it was attributable to subcortical hemorrhage and in 3 cases it was attributable to lacunar infarction."
    explanation: >-
      Six hemorrhagic and three ischemic strokes in an ascertained 52-carrier series; total stroke frequency
      is not hemorrhage frequency.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Neurological
  name: Infantile hemiparesis
  description: >-
    Hemiparesis presenting in infancy, one of the classic presenting signs of
    COL4A1 porencephaly / small-vessel disease.
  phenotype_term:
    preferred_term: Infantile hemiparesis
    term:
      id: HP:0001269
      label: Hemiparesis
    onset:
      onset_category: INFANTILE
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura."
    explanation: GeneReviews lists infantile hemiparesis as a core manifestation.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Neurological
  name: Seizures
  description: Seizures may follow early brain injury; childhood epilepsy can include infantile spasms and refractory syndromes. In a retrospective COL4A1 cohort, eight of seventeen perinatal-onset and five of nine early-childhood-onset patients had epilepsy. These selected onset groups include clinically consistent VUS and do not define overall disease frequency.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability"
    explanation: GeneReviews lists seizures among porencephaly manifestations.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Epilepsy was seen in 8/17 (47%) and treatment refractory in most (6/8, 75%).
    explanation: COL4A1 perinatal-onset subgroup of a retrospective pediatric cohort.
    quote_role: PRIMARY_RESULT
- category: Neurological
  name: Intellectual disability
  description: Intellectual disability, often correlating with the extent of hemorrhagic brain injury.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability"
    explanation: GeneReviews lists intellectual disability among porencephaly manifestations.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Neurological
  name: Ischemic stroke
  description: >-
    Lacunar ischemic stroke occurs in some carriers. Three of 52 individuals in the 2010 review had a clinical
    lacunar stroke. Silent lacunar lesions on imaging are a separate endpoint and cannot be used as the symptomatic
    stroke frequency.
  phenotype_term:
    preferred_term: Lacunar ischemic stroke
    term:
      id: HP:0032325
      label: Lacunar stroke
  evidence:
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "in 3 cases it was attributable to lacunar infarction."
    explanation: >-
      Clinical stroke attribution in three of 52 literature cases; distinct from silent imaging lacunes and
      not an unbiased population estimate.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Neurological
  name: Leukoencephalopathy
  description: >-
    Diffuse or patchy periventricular and other white-matter abnormalities can occur with severe early brain
    injury or as the principal finding in milder and clinically asymptomatic carriers. The high imaging prevalence
    in selected published carriers is not a population penetrance estimate.
  phenotype_term:
    preferred_term: Diffuse leukoencephalopathy
    term:
      id: HP:0002352
      label: Leukoencephalopathy
  evidence:
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Brain imaging showed frequent leukoaraiosis (63.5%),"
    explanation: >-
      Describes an imaging finding in selected reported carriers; not an unselected population prevalence.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Neurological
  name: Cerebral microbleeds
  description: Small cerebral hemorrhagic deposits detected on susceptibility-sensitive MRI. The binding is to cerebral hemorrhage because an exact microbleed term was not identified; this imaging phenotype is distinct from a symptomatic hemorrhagic stroke. The 2010 reported imaging percentage has an incompletely specified screened denominator in the available abstract.
  phenotype_term:
    preferred_term: Cerebral microbleeds
    term:
      id: HP:0001342
      label: Cerebral hemorrhage
  evidence:
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "microbleeds that are usually subcortical (52.9%),"
    explanation: >-
      Describes an imaging finding in selected reported carriers; not an unselected population prevalence.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Neurological
  name: Migraine with aura
  description: >-
    Migraine with aura may be an isolated clinical presentation. The 2010 review counted ten migraine cases
    with or without aura among 52 carriers, so that figure is not an aura-specific frequency.
  phenotype_term:
    preferred_term: Migraine with aura
    term:
      id: HP:0002077
      label: Migraine with aura
  evidence:
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: ischemic stroke, and isolated migraine with aura.
    explanation: GeneReviews explicitly identifies migraine with aura.
    quote_role: REVIEW_SYNTHESIS
- category: Vascular
  name: Intracranial aneurysm
  description: >-
    Intracranial aneurysms, often at the carotid siphon, are particularly associated with the HANAC end of
    the spectrum. Eight of eighteen angiographically assessed individuals had asymptomatic aneurysms in the
    selected 2010 review; this screened subset is not the entire carrier population. The HPO binding retains
    the current canonical cerebral-artery-dilatation label.
  phenotype_term:
    preferred_term: Intracranial aneurysm
    term:
      id: HP:0004944
      label: Dilatation of the cerebral artery
  evidence:
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Asymptomatic intracranial aneurysms were common (44.4% of 18 with angiography)."
    explanation: >-
      Eight of eighteen angiographically investigated carriers, with screening-selection limitations.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Ocular
  name: Axenfeld-Rieger anomaly
  description: >-
    Anterior-segment dysgenesis of the Axenfeld-Rieger type, with variable iris abnormalities and posterior
    embryotoxon. The combined clinical description is bound to anterior-segment dysgenesis, rather than equating
    it solely with the narrower Axenfeld anomaly.
  phenotype_term:
    preferred_term: Axenfeld-Rieger-type anterior segment dysgenesis
    term:
      id: HP:0007700
      label: Ocular anterior segment dysgenesis
  evidence:
  - reference: PMID:17696175
    reference_title: "COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diffuse leukoencephalopathy associated with ocular malformations of the Axenfeld-Rieger type was observed in five individuals."
    explanation: Documents the Axenfeld-Rieger anomaly in a COL4A1 family.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- category: Ocular
  name: Cataract
  description: >-
    Developmental cataract may accompany anterior-segment dysgenesis or be the main ocular finding. Prenatal
    intracranial hemorrhage with lens abnormalities is a diagnostic clue.
  phenotype_term:
    preferred_term: Congenital cataract
    term:
      id: HP:0000519
      label: Developmental cataract
  evidence:
  - reference: PMID:24374867
    reference_title: "Fetal intracerebral hemorrhage and cataract: think COL4A1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report two cases of prenatal ICH associated with cataract and suggest that COL4A1 mutation should be envisaged in fetuses with prenatal ICH, especially in the presence of lens abnormalities at ultrasound examination."
    explanation: Associates cataract with prenatal COL4A1 disease.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- category: Ocular
  name: Retinal arterial tortuosity
  description: >-
    Bilateral tortuosity of the second- and third-order retinal arterioles
    (first-order vessels spared), which can bleed after minor trauma causing
    transient visual loss.
  phenotype_term:
    preferred_term: Retinal arterial tortuosity
    term:
      id: HP:0000631
      label: Retinal arterial tortuosity
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract)"
    explanation: GeneReviews lists retinal arterial tortuosity among the ocular defects.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Ocular
  name: Glaucoma
  description: Secondary congenital or juvenile glaucoma arising from the anterior-segment dysgenesis.
  phenotype_term:
    preferred_term: Glaucoma
    term:
      id: HP:0000501
      label: Glaucoma
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: posterior embryotoxon, microcornea, increased intraocular pressure, and glaucoma.
    explanation: Human clinical spectrum summarized in GeneReviews; no COL4A1-specific 50–75% risk is asserted.
    quote_role: REVIEW_SYNTHESIS
- category: Renal
  name: Hematuria
  description: Microscopic or episodic gross hematuria occurs with COL4A1 renal involvement, including HANAC presentations. Human ultrastructure implicates multiple renal basement-membrane compartments; a uniformly glomerular bleeding mechanism is not established.
  phenotype_term:
    preferred_term: Hematuria
    term:
      id: HP:0000790
      label: Hematuria
  evidence:
  - reference: PMID:18160688
    reference_title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The clinical renal manifestations of the HANAC syndrome in these families include hematuria and bilateral, large cysts."
    explanation: Documents hematuria as a renal manifestation.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- category: Renal
  name: Renal cysts
  description: Bilateral, often large renal cysts.
  phenotype_term:
    preferred_term: Renal cyst
    term:
      id: HP:0000107
      label: Renal cyst
  evidence:
  - reference: PMID:18160688
    reference_title: "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hematuria and bilateral, large cysts."
    explanation: Documents bilateral renal cysts.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- category: Musculoskeletal
  name: Muscle cramps
  description: Painful muscle cramps, part of the HANAC constellation, with early onset in HANAC families.
  phenotype_term:
    preferred_term: Muscle cramps
    term:
      id: HP:0003394
      label: Muscle spasm
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia)"
    explanation: GeneReviews lists muscle cramps among systemic findings.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Musculoskeletal
  name: Elevated creatine kinase
  description: Serum creatine kinase elevation may occur with or without cramps. It was consistently described in the small HANAC families summarized by GeneReviews, but is variable in the broader COL4A1 cerebrovascular spectrum.
  phenotype_term:
    preferred_term: Elevated circulating creatine kinase activity
    term:
      id: HP:0003236
      label: Elevated circulating creatine kinase activity
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: serum CK elevation with or without muscle cramps
    explanation: Directly states the laboratory finding; not inferred solely from the presence of myopathy.
    quote_role: REVIEW_SYNTHESIS
- category: Vascular
  name: Raynaud phenomenon
  description: Raynaud phenomenon, a recognized systemic feature.
  phenotype_term:
    preferred_term: Raynaud phenomenon
    term:
      id: HP:0030880
      label: Raynaud phenomenon
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia)"
    explanation: GeneReviews lists Raynaud phenomenon among systemic findings.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Cardiovascular
  name: Cardiac arrhythmia
  description: Cardiac arrhythmia, a recognized systemic feature of the spectrum.
  phenotype_term:
    preferred_term: Arrhythmia
    term:
      id: HP:0011675
      label: Arrhythmia
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cardiac arrhythmia, and hemolytic anemia"
    explanation: GeneReviews lists cardiac arrhythmia among systemic findings.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- category: Hematologic
  name: Hemolytic anemia
  description: Hemolytic anemia, a recognized systemic feature of the spectrum.
  phenotype_term:
    preferred_term: Hemolytic anemia
    term:
      id: HP:0001878
      label: Hemolytic anemia
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cardiac arrhythmia, and hemolytic anemia"
    explanation: GeneReviews lists hemolytic anemia among systemic findings.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
- name: Dystonia
  category: Neurological
  description: Dystonia is a variable manifestation in individuals with COL4A1 porencephaly.
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: infantile hemiparesis, seizures, intellectual disability, dystonia, stroke, and migraine.
    explanation: GeneReviews clinical manifestations.
    quote_role: REVIEW_SYNTHESIS
- name: Dilated perivascular spaces
  category: Neurological
  description: Dilated cerebral perivascular spaces are part of the small-vessel imaging phenotype.
  phenotype_term:
    preferred_term: Dilation of Virchow-Robin spaces
    term:
      id: HP:0012520
      label: Dilation of Virchow-Robin spaces
  evidence:
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages.
    explanation: GeneReviews imaging spectrum.
    quote_role: REVIEW_SYNTHESIS
- name: Intracerebral calcification
  category: Neurological
  description: Intracerebral calcifications can accompany the vascular brain imaging phenotype.
  phenotype_term:
    preferred_term: Cerebral calcification
    term:
      id: HP:0002514
      label: Cerebral calcification
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: deep intracerebral hemorrhages, and intracerebral calcifications
    explanation: Full GeneReviews description of the BSVD imaging pattern.
    quote_role: REVIEW_SYNTHESIS
- name: Retinal hemorrhage
  category: Ocular
  description: Retinal arterial tortuosity may be accompanied by spontaneous or stress-associated retinal hemorrhage and transient visual loss.
  phenotype_term:
    preferred_term: Retinal hemorrhage
    term:
      id: HP:0000573
      label: Retinal hemorrhage
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Affected individuals experience episodic transient visual loss as a result of retinal hemorrhage occurring spontaneously or after minor stress or trauma.
    explanation: Full chapter directly links the retinal finding to transient symptoms.
    quote_role: REVIEW_SYNTHESIS
- name: Unilateral renal atrophy
  category: Renal
  description: Reported in a small number of individuals with COL4A1-related disease; not assigned a population frequency.
  phenotype_term:
    preferred_term: Unilateral renal atrophy
    term:
      id: HP:0008717
      label: Unilateral renal atrophy
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Unilateral renal atrophy ... has been reported in two individuals
    explanation: Specific full-chapter renal finding.
    quote_role: REVIEW_SYNTHESIS
- name: Decreased glomerular filtration rate
  category: Renal
  description: Declining filtration has been reported, particularly in adults with renal/HANAC manifestations; renal severity is variable.
  phenotype_term:
    preferred_term: Decreased glomerular filtration rate
    term:
      id: HP:0012213
      label: Decreased glomerular filtration rate
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Glomerular filtration rate decrease ... has been observed in individuals with HANAC
    explanation: Age-qualified renal observation from the full chapter.
    quote_role: REVIEW_SYNTHESIS
- name: Mitral valve prolapse
  category: Cardiovascular
  description: A reported cardiac manifestation within the COL4A1 spectrum, with limited case numbers.
  phenotype_term:
    preferred_term: Mitral valve prolapse
    term:
      id: HP:0001634
      label: Mitral valve prolapse
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Mitral valve prolapse and supraventricular arrythmia have been characterized in four patients
    explanation: Full chapter describes both findings in a small reported set.
    quote_role: REVIEW_SYNTHESIS
- name: Global developmental delay
  category: Neurological
  description: Developmental impairment is prominent in some children with early-onset disease. In the 2026 COL4A1 perinatal subgroup, eleven of seventeen had global delay; referral and short follow-up limit generalization.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Developmental delays were seen in most patients (15/17, 88%) and were frequently global (11/17, 65%).
    explanation: COL4A1 perinatal subgroup.
    quote_role: PRIMARY_RESULT
- name: Cerebral palsy
  category: Neurological
  description: Persistent early motor impairment may be severe after prenatal/perinatal brain injury. Eleven of seventeen perinatal-onset COL4A1 patients had cerebral palsy in one retrospective cohort.
  phenotype_term:
    preferred_term: Cerebral palsy
    term:
      id: HP:0100021
      label: Cerebral palsy
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: CP diagnosis was common (11/17, 65%) and frequently severe (7/17 with GMFCS ≥4, 41%)
    explanation: COL4A1 perinatal subgroup; not combined-gene prevalence.
    quote_role: PRIMARY_RESULT
- name: Ventriculomegaly
  category: Neurological
  description: Ventricular enlargement accompanies severe early brain injury in some children; it is not synonymous with pressure-driven hydrocephalus.
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Ventriculomegaly was common (13/17, 76%) with posthemorrhagic hydrocephalus in 3 patients
    explanation: Imaging findings in the COL4A1 perinatal subgroup.
    quote_role: PRIMARY_RESULT
- name: Schizencephaly
  category: Neurological
  description: A minority of severe perinatal presentations show schizencephalic clefts; destructive vascular injury and developmental timing complicate mechanistic interpretation.
  phenotype_term:
    preferred_term: Schizencephaly
    term:
      id: HP:0010636
      label: Schizencephaly
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Schizencephaly and porencephaly were evident in some (4/17, 24%, and 9/17, 53%, respectively).
    explanation: COL4A1 perinatal subgroup imaging.
    quote_role: PRIMARY_RESULT
- name: Microphthalmia
  category: Ocular
  description: Microphthalmia is one of the reported developmental ocular findings.
  phenotype_term:
    preferred_term: Microphthalmia
    term:
      id: HP:0000568
      label: Microphthalmia
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: including cataracts, glaucoma, microphthalmia, and anterior segment dysgenesis
    explanation: Ophthalmologic findings in the COL4A1 perinatal subgroup.
    quote_role: PRIMARY_RESULT
- name: Feeding difficulties
  category: Gastrointestinal
  description: Feeding difficulties may accompany severe neurologic disease; six of seventeen perinatal-onset COL4A1 patients required surgical feeding tubes in one cohort.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Feeding difficulties, conversely, were common (9/17, 53%) with frequent placement of surgical feeding tubes (6/17, 35%).
    explanation: Direct clinical observation in a selected early-onset group.
    quote_role: PRIMARY_RESULT
- name: Sensorineural hearing impairment
  category: Auditory
  description: Reported in two adolescents in the COL4A1 late-childhood group in a 2026 cohort. This is a preliminary association requiring replication and consideration of alternative causes.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: we identified 2 adolescents with sensorineural hearing loss in addition to neuroimaging and renal features typical of COL4A1/2-related disorders.
    explanation: Full Table 1 places both in the COL4A1 late-childhood subgroup; a new, limited observation.
    quote_role: PRIMARY_RESULT
imaging_findings:
- name: Small-vessel disease on brain MRI
  description: >-
    Brain MRI may show periventricular hemorrhagic infarction, porencephalic cavities, diffuse or patchy white-matter
    abnormality, lacunes, microbleeds and dilated perivascular spaces. Some clinically asymptomatic carriers
    have abnormal imaging. Dedicated vascular imaging assesses aneurysms and vessel tortuosity. The 2026 pediatric
    study adapted an injury-severity score from another population; it is not a validated diagnostic or prognostic
    score for COL4A1 disease.
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy,
      lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages.
    explanation: >-
      GeneReviews core imaging findings; variable clinical expression is described separately.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dilated perivascular spaces (19.2%)."
    explanation: Quantifies dilated perivascular spaces among carriers.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
environmental:
- name: Environmental "second hit" precipitants of hemorrhage
  description: >-
    Trauma, intense exertion, anticoagulant exposure and vascular risk factors can modify hemorrhagic susceptibility;
    hemorrhage may also occur spontaneously or prenatally before delivery. These exposures are risk modifiers
    rather than required causes. Mouse surgical-delivery protection does not establish a universal human delivery
    recommendation.
  evidence:
  - reference: PMID:15905400
    reference_title: "Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we propose that Col4a1 mutations conspire with environmental trauma in causing the disease."
    explanation: Establishes the gene-environment (second-hit) model.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
  - reference: PMID:25753534
    reference_title: "Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "environmental factors such as intense exercise or anticoagulant medication modulated disease severity"
    explanation: Identifies specific environmental modifiers of severity.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
diagnosis:
- name: COL4A1 molecular genetic testing
  description: >-
    Diagnosis combines compatible clinical/imaging findings with a pathogenic or likely pathogenic COL4A1 variant.
    Multigene testing including COL4A1 and COL4A2 is useful because phenotypes overlap; negative testing with
    strong suspicion may justify broader genomic analysis, including poorly covered or intronic regions. A
    VUS alone is not confirmatory. Baseline multiorgan assessment is advised even when symptoms are mild.
  evidence:
  - reference: PMID:20301768
    reference_title: "COL4A1-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diagnosis is based on clinical findings and molecular genetic testing of COL4A1."
    explanation: GeneReviews diagnostic principle.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Genome sequencing is recommended in patients with a nega- tive panel or exome if there is high suspicion
    explanation: Full consensus provides a conditional broader-testing strategy.
    quote_role: REVIEW_SYNTHESIS
  diagnosis_term:
    preferred_term: Genetic Testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
- name: Fetal/neonatal imaging clue
  description: >-
    Prenatal intracranial hemorrhage, especially with cataract or other lens abnormalities, should raise suspicion
    for COL4A1 disease. This combination is a diagnostic clue rather than a pathognomonic finding.
  evidence:
  - reference: PMID:24374867
    reference_title: "Fetal intracerebral hemorrhage and cataract: think COL4A1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "COL4A1 mutation should be envisaged in fetuses with prenatal ICH, especially in the presence of lens abnormalities at ultrasound examination."
    explanation: Establishes the prenatal ICH-plus-cataract diagnostic clue.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- name: Multiorgan baseline assessment
  description: Brain MRI and head/neck vascular imaging, ophthalmologic assessment, renal imaging and renal-function/urine evaluation, CK measurement and cardiac assessment help define involvement. The 2025 consensus extends systematic cardiac screening to ECG and echocardiography. Choice and timing of repeated tests are individualized.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Measurement of serum CK concentration
    explanation: Full-chapter baseline assessment includes CK rather than inferring myopathy.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Cardiovascular screening including blood pressure
    explanation: Expert-consensus baseline assessment; not a validated outcome-based screening trial.
    quote_role: REVIEW_SYNTHESIS
treatments:
- name: Supportive and rehabilitative care
  description: Individualized care addresses motor disability, development, communication and practical family support. Feeding assessment and enteral access may be needed in children with severe neurologic impairment. This is a multidisciplinary intervention rather than a purely behavioral treatment.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  evidence:
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Supportive care tailored to the individual’s specific medical needs and including practical help and emotional support for affected individuals and their families.
    explanation: GeneReviews general management.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Feeding difficulties, conversely, were common (9/17, 53%) with frequent placement of surgical feeding tubes (6/17, 35%).
    explanation: Clinical use of feeding support in the COL4A1 perinatal subgroup.
    quote_role: PRIMARY_RESULT
- name: Seizure treatment
  description: Antiseizure treatment follows the seizure syndrome and individual response. A pediatric COL4A1 cohort also reported ketogenic diet and epilepsy surgery in selected refractory cases; these observations do not establish one preferred drug or procedure for all carriers.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Seizures are managed using standard protocols.
    explanation: GeneReviews treatment recommendation.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: including ketogenic diet (3/5, 60%) and epilepsy surgery (3/5, 60%).
    explanation: Selected children with epilepsy in the early-childhood COL4A1 subgroup.
    quote_role: PRIMARY_RESULT
- name: Blood-pressure control
  description: Treat hypertension and monitor blood pressure to reduce vascular risk. The 2025 consensus also emphasizes peri-procedural pressure support. Benefit is based on risk-management guidance, not a COL4A1-specific randomized antihypertensive trial.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Hypertension should be treated to reduce the overall risk of stroke.
    explanation: GeneReviews recommendation.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: consider strict peri-procedural blood pressure support
    explanation: Consensus recommends attention to pressure during procedures.
    quote_role: REVIEW_SYNTHESIS
- name: Hemorrhage-risk reduction and individualized antithrombotic decisions
  description: Avoid smoking and head trauma, and avoid prolonged strenuous exertion while maintaining appropriate aerobic activity. Antiplatelet and anticoagulant treatment is generally discouraged for routine prevention, but a strong competing indication or ischemic stroke without prior intracranial hemorrhage warrants multidisciplinary assessment. This is not an absolute prohibition under all circumstances.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  evidence:
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Avoiding head trauma and anticoagulant exposure may decrease the risk for intracerebral hemorrhage.
    explanation: GeneReviews precaution.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: beneﬁts should be discussed with a multidisciplinary team in cases of ischemic stroke
    explanation: 2025 consensus explicitly allows individualized assessment of competing indications.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: Continue aerobic exercise while avoiding strenuous,
    explanation: Exercise guidance distinguishes appropriate aerobic activity from strenuous exertion.
    quote_role: REVIEW_SYNTHESIS
- name: Ophthalmologic treatment
  description: Treat cataract and glaucoma according to the affected structures and visual risk. Severe lens opacity may require cataract surgery. Glaucoma is initially treated with topical medication, with surgery when medical treatment is inadequate.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Cataract surgery may be required for individuals with severe lens opacities.
    explanation: Specific clinical intervention in the full chapter.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Glaucoma is initially treated with topical anti-glaucoma medication. Surgery is reserved for eyes that do not respond to medical therapy.
    explanation: GeneReviews stepwise glaucoma care.
    quote_role: REVIEW_SYNTHESIS
- name: Multiorgan surveillance
  description: Regular clinical follow-up and surveillance of neurologic, ophthalmic, renal and cardiac involvement are individualized. GeneReviews regards annual clinical review as reasonable and proposes imaging for aneurysm follow-up. The 2025 consensus proposes repeat adult vascular imaging about every five years when an aneurysm is absent, with closer follow-up when indicated; these are expert recommendations rather than validated universal intervals.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Annual clinical evaluation is reasonable.
    explanation: Full-chapter follow-up recommendation.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Regular brain imaging can be proposed, especially to evaluate the size of asymptomatic cerebral aneurysms.
    explanation: Imaging surveillance recommendation.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: every 5 years, unless aneurysm is observed
    explanation: Consensus adult vascular-imaging interval, individualized if an aneurysm is present.
    quote_role: REVIEW_SYNTHESIS
- name: Symptomatic supraventricular arrhythmia treatment
  description: Beta-blocker treatment may be used for symptomatic paroxysmal supraventricular arrhythmia, with cardiac evaluation guiding management.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Beta-Adrenergic Antagonist
      term:
        id: NCIT:C29576
        label: Beta-Adrenergic Antagonist
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Symptomatic paroxysmal supraventricular arrhythmia should be treated with antiarrhythmic drugs (beta blockers).
    explanation: GeneReviews symptomatic treatment recommendation.
    quote_role: REVIEW_SYNTHESIS
- name: Renal management
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  description: Renal follow-up includes filtration, blood pressure, urinalysis and imaging as indicated. Proteinuria prompts nephrology assessment and consideration of renin-angiotensin-aldosterone system blockade; reduced kidney function or cystic disease warrants specialist care. This is consensus-based clinical management, not a disease-specific drug trial.
  evidence:
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: If proteinuria is present, refer the patient to a nephrologist
    explanation: 2025 consensus recommendation for renal specialist management.
    quote_role: REVIEW_SYNTHESIS
- name: Intracranial aneurysm intervention
  description: Surgical or endovascular treatment is considered according to aneurysm anatomy, size and individual risk. GeneReviews discusses asymptomatic aneurysms larger than 10 mm; this is not a universal intervention threshold validated specifically for every COL4A1 carrier.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Surgical Procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Surgical or endovascular treatment should be discussed for asymptomatic intracranial aneurysms ... 10.0 mm in diameter.
    explanation: Full-chapter management guidance, explicitly attributed.
    quote_role: REVIEW_SYNTHESIS
- name: Genetic and reproductive counseling
  description: Discuss autosomal dominant transmission, uncertain severity, family testing and reproductive options. Prenatal and preimplantation genetic testing can be considered once a familial pathogenic variant is known. The historical de novo fraction is not a recurrence-risk calculation.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301768
    reference_title: COL4A1-Related Disorders.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Each child of an individual with a COL4A1-related disorder has a 50% chance of inheriting the pathogenic variant.
    explanation: Transmission risk differs from penetrance and severity.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK7046/
    reference_title: COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: prenatal testing for a pregnancy at increased risk
    explanation: Full-chapter reproductive testing discussion; familial variant identification is required.
    quote_role: REVIEW_SYNTHESIS
- name: Individualized pregnancy and delivery planning
  description: A specialist obstetric and fetal/neonatal team should consider the maternal and fetal genotype and clinical condition. The 2025 consensus makes cesarean delivery a case-by-case option when mother or fetus carries a pathogenic variant, updating the blanket recommendation in the older GeneReviews chapter. A 2026 retrospective combined-gene pediatric study found no association between delivery mode and several childhood outcomes, but confounding by prenatal injury and small sample size prevent a conclusion of equivalent safety.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  evidence:
  - reference: url:https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf
    reference_title: "https://air.unimi.it/bitstream/2434/1187255/2/1-s2.0-S1098360025001613-main.pdf"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: A cesarean delivery may be considered in a case-by- case basis when a mother or fetus has a known path- ogenic COL4A1 or COL4A2 variant.
    explanation: Current expert-consensus qualification.
    quote_role: REVIEW_SYNTHESIS
  - reference: PMID:42605108
    reference_title: "Perinatal complications, mode of delivery, and neurological morbidity in children with COL4A1/A2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: no association was detected between these diagnoses and delivery type.
    explanation: Retrospective combined-gene observational evidence; no causal delivery comparison.
    quote_role: PRIMARY_RESULT
- name: Sodium phenylbutyrate (preclinical)
  description: The chemical chaperone sodium 4-phenylbutyrate promotes collagen secretion and can reduce retention and selected disease outcomes in mice. Responses depend on mutation, tissue, dose and treatment timing. Delta-exon-41 myopathy improves, whereas G394V muscle histology worsens despite improved peripheral myelination. In G1064D mice, preventive treatment reduces MRI hemorrhage volume; adult treatment reduces histologic hemosiderin without a clear MRI burden change. Matrix structural defects persist and skin mechanical stability can worsen. Ocular rescue at high prenatal doses in another model coincides with maternal/perinatal toxicity. These findings do not establish human efficacy or a safe disease-specific regimen.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Sodium Phenylbutyrate
      term:
        id: NCIT:C1440
        label: Sodium Phenylbutyrate
  evidence:
  - reference: PMID:29895609
    reference_title: Use of sodium 4-phenylbutyrate to define therapeutic parameters for reducing intracerebral hemorrhage and myopathy in Col4a1 mutant mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: We show the efficacy of long-term 4PBA treatment in reducing the severity of intracerebral hemorrhages (ICHs) in Col4a1 mutant mice aged up to 8 months.
    explanation: Timing and dose experiments in mutant mice.
    quote_role: PRIMARY_RESULT
  - reference: PMID:31051113
    reference_title: COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: 4PBA treatment exacerbated myopathy in Col4a1+/G394V mice
    explanation: Direct genotype-dependent preclinical harm.
    quote_role: PRIMARY_RESULT
  - reference: PMID:30351356
    reference_title: 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: the persistence of defects in BM structure and reduced ability of the BM to withstand mechanical stress
    explanation: Abstract identifies matrix-related limitations; full text localizes mechanical testing to skin.
    quote_role: PRIMARY_RESULT
  - reference: PMID:35525525
    reference_title: Elevated TGFβ signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: dystocia and perinatal lethality associated with embryonic administration of 100 mM 4PBA or losartan
    explanation: Preclinical embryonic regimens have important toxicity.
    quote_role: PRIMARY_RESULT
  - reference: url:https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6360271/fullTextXML
    reference_title: Abstract
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: While ICH severity was maintained on MRI analysis ... ICH was significantly reduced based on histopathology using Perl’s stain
    explanation: Full XML distinguishes adult histological improvement from unchanged MRI burden.
    quote_role: PRIMARY_RESULT
  target_mechanisms:
  - target: Intracellular Collagen IV Retention
    treatment_effect: MODULATES
    description: Promotes export of retained collagen in responsive preclinical models; extracellular quality may remain abnormal.
- name: Matrix metalloproteinase inhibition (preclinical)
  description: Doxycycline and marimastat partially rescue matrix deposition, migration, apoptosis and endothelial-junction phenotypes in human iPSC-derived COL4A1/COL4A2 models. A zebrafish col4a1-loss study also reports partial vascular rescue after MMP9 inhibition. These culture and animal results do not establish clinical efficacy; the observational MMP biomarker study is not a drug trial.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Doxycycline
      term:
        id: NCIT:C457
        label: Doxycycline
    - preferred_term: Marimastat
      term:
        id: NCIT:C1652
        label: Marimastat
  evidence:
  - reference: PMID:37977146
    reference_title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: inhibiting MMP activity partially rescues the ECM abnormalities and mural cell phenotypic changes.
    explanation: Human-cell model result, not treated-patient evidence.
    quote_role: PRIMARY_RESULT
  - reference: url:https://eprints.gla.ac.uk/309664/1/309664.pdf
    reference_title: "https://eprints.gla.ac.uk/309664/1/309664.pdf"
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: targeting MMPs using the pan-MMP inhibitor DOXY partially rescued the disease MC phenotypes
    explanation: Full-paper doxycycline result.
    quote_role: PRIMARY_RESULT
  - reference: PMID:40846110
    reference_title: Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: Pharmacological inhibition of mmp9 was sufficient to ameliorate some cerebrovascular phenotypes.
    explanation: Zebrafish loss model; no claim of complete rescue.
    quote_role: PRIMARY_RESULT
  target_mechanisms:
  - target: Increased Matrix Metalloproteinase Activity
    treatment_effect: INHIBITS
    description: Broad MMP inhibition tests a candidate proteolytic contribution in preclinical systems.
- name: TGF-beta pathway inhibition (preclinical)
  description: Genetic Tgfb1 reduction and a pan-TGF-beta antibody provide mouse proof of mechanism. Acute SB-431542 or PI3K inhibitor GSK1059615 restores myogenic tone at physiological, but not high, pressures in isolated G394V cerebral arteries. Gestational losartan improves corneal thickness in some alleles but increases postnatal death and does not clearly normalize the selected TGF-beta target genes; that regimen is not a viable therapy. No disease-specific human benefit has been established.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Therapeutic Procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
    therapeutic_agent:
    - preferred_term: Losartan
      term:
        id: NCIT:C66869
        label: Losartan
  evidence:
  - reference: PMID:36693102
    reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: the myogenic tone was not improved at higher pressure levels
    explanation: Ex vivo pharmacologic rescue is pressure-limited.
    quote_role: PRIMARY_RESULT
  - reference: PMID:35525525
    reference_title: Elevated TGFβ signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: gestational administration of losartan was also associated with increased postnatal death
    explanation: Mouse ocular intervention carries explicit toxicity and mechanistic uncertainty.
    quote_role: PRIMARY_RESULT
  - reference: PMID:35525525
    reference_title: Elevated TGFβ signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: we did not detect an effect of losartan on the expression of TGFβ target genes
    explanation: Losartan ocular protection does not prove suppression of the measured pathway targets.
    quote_role: PRIMARY_RESULT
  target_mechanisms:
  - target: Increased TGF-beta Signaling
    treatment_effect: MODULATES
    description: Preclinical genetic and pharmacologic perturbations support pathway involvement; losartan target-gene effects were inconclusive.
prevalence:
- population: Worldwide
  measure_type: UNKNOWN
  notes: Population prevalence is not established. Published clinical series and literature compilations are ascertained, often combine COL4A1 and COL4A2, and have variable screening. Their case counts cannot support an ultra-rare numerical prevalence class.
  evidence:
  - reference: PMID:39016117
    reference_title: Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: 43 individuals from 23 distinct families carrying pathogenic variants.
    explanation: Size of an ascertained combined-gene clinical cohort, not a population estimate.
    quote_role: PRIMARY_RESULT
progression:
- phase: Prenatal / perinatal
  age_range: In utero to neonatal
  notes: >-
    Intracranial hemorrhage can occur antenatally (detectable on fetal ultrasound)
    or perinatally, precipitated by delivery, producing porencephaly, infantile
    hemiparesis, and seizures at the severe end.
  evidence:
  - reference: PMID:24374867
    reference_title: "Fetal intracerebral hemorrhage and cataract: think COL4A1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "several authors have reported mutations in COL4A1 as a Mendelian cause of prenatal onset intracranial hemorrhage (ICH)."
    explanation: Documents the prenatal/perinatal onset window.
    directness: DIRECT
    quote_role: PRIMARY_RESULT
- phase: Childhood presentations
  age_range: Infancy through adolescence
  notes: A retrospective cohort distinguished perinatal, early-childhood and late-childhood presentations. Earlier onset correlated with greater neurologic impairment, whereas later presentations more often showed isolated leukoencephalopathy. These are provisional clinical strata, not validated molecular subtypes or inevitable sequential stages. Clinical onset must be distinguished from delayed genetic diagnosis.
  evidence:
  - reference: PMID:42099677
    reference_title: Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: Perinatal and early childhood presentations exhibit a more prominent neurologic phenotype compared with late childhood presentations.
    explanation: Combined-gene cohort conclusion, with gene-specific findings separately reported.
    quote_role: PRIMARY_RESULT
- phase: Adulthood
  age_range: Adult
  notes: >-
    In milder cases the disease presents in adulthood as small-vessel disease —
    ischemic or hemorrhagic stroke (mean stroke onset ~36 years), migraine,
    leukoencephalopathy, and aneurysms — sometimes as the first manifestation.
  evidence:
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "have been recently recognized as a further monogenic cause of small vessel disease that can present in adulthood."
    explanation: Documents adult-onset small-vessel-disease presentation.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
differential_diagnoses:
- name: Other hereditary cerebral small-vessel diseases
  description: >-
    CADASIL (NOTCH3), CARASIL (HTRA1), and other monogenic small-vessel diseases
    share leukoencephalopathy and stroke; the presence of porencephaly, ocular
    anterior-segment anomalies, retinal arterial tortuosity, or the HANAC systemic
    features (hematuria, renal cysts, muscle cramps, aneurysms) points to COL4A1.
  evidence:
  - reference: PMID:20558831
    reference_title: "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A number of single gene disorders can cause cerebral small vessel disease."
    explanation: Situates COL4A1 among the monogenic small-vessel diseases requiring differentiation.
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
discussions:
- discussion_id: bsvd1_intracellular_vs_extracellular_mechanism
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Which COL4A1 variants and tissues are driven predominantly by intracellular retention, quantitative deficiency
    or extracellular mutant-collagen dysfunction?
  attaches_to:
  - pathophysiology#Intracellular Collagen IV Retention
  - pathophysiology#Abnormal Extracellular Collagen IV Network
  rationale: >-
    Human haploinsufficiency, secretion-impaired mouse alleles, lenses without measurable UPR, and mutation-dependent
    chaperone benefit or harm demonstrate that a single retention-to-apoptosis pathway is insufficient. Retinal
    NOTCH3/TGF-beta, arterial PIP2/calcium and human iPSC metalloproteinase findings identify further context-dependent
    branches. Their relative contributions in individual patients remain uncertain.
  evidence:
  - reference: PMID:31051113
    reference_title: COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: can ameliorate or exacerbate myopathy in a mutation-dependent manner
    explanation: Contrasting preclinical treatment response motivates genotype and tissue stratification.
    quote_role: PRIMARY_RESULT
  - reference: PMID:23065703
    reference_title: Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs) and a clear reduction of COL4A1 protein expression were demonstrated
    explanation: Human quantitative deficiency provides a distinct mechanistic case.
    quote_role: PRIMARY_RESULT
notes: >-
  This entry retains the cerebrovascular-predominant COL4A1 BSVD1 concept (MONDO:0008289), including variably
  overlapping renal, muscular and ocular findings. HANAC-associated systemic manifestations are qualified by
  their ascertainment; isolated retinal arterial tortuosity and PADMAL due to COL4A1 overexpression are not
  treated as equivalent diagnoses. COL4A2 models provide explicitly comparative evidence. Published cohort
  fractions depend on genotype mix, referral patterns, age and which organs were screened, and are not population
  penetrance estimates.
clinical_trials:
- name: NCT01097564
  status: COMPLETED
  description: Prospective multicenter observational cohort characterizing clinical, imaging and mutational features of COL4A1 disease. It does not test a disease-modifying drug.
  notes: ClinicalTrials.gov status checked 2026-10-01.
  evidence:
  - reference: clinicaltrials:NCT01097564
    reference_title: "COL4A1 Gene Related Cerebra-retinal Angiopathy : Clinical Spectrum From Children to Adult, Mutational Spectrum and Application to Routine Management of Affected Patients : a Prospective Cohort Study"
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: This prospective multicenter cohort study aims to define the clinical, radiological and mutational spectrum of the disease related to COL4A1 gene.
    explanation: Registry study objective.
- name: NCT07374913
  status: RECRUITING
  description: Observational diagnostic study of COL4A1/COL4A2 families, including eye/heart screening and blood MMP2/MMP9 analyses. Biomarker measurements are exploratory rather than validated diagnostic tests or evidence for an MMP inhibitor.
  notes: ClinicalTrials.gov status checked 2026-10-01; combined-gene population.
  evidence:
  - reference: clinicaltrials:NCT07374913
    reference_title: Study of the Familial Phenotype Associated With Mutations in the COL4A1 and COL4A2 Genes
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: blood samples will be analyzed to study the activity of specific enzymes called matrix metalloproteinases (MMP2 and MMP9)
    explanation: Registry describes planned measurement, not a completed treatment result.
animal_models:
- name: Col4a1 delta-exon-41 constitutive and conditional mice
  species: Mouse
  genotype: Heterozygous Col4a1 delta-exon-41; conditional Flex41 recombination in selected lineages
  publication: PMID:25753534
  description: Models developmental vascular abnormalities, porencephaly and recurrent hemorrhage. Endothelial/pericyte expression produces hemorrhage; genetic background and timing strongly modify severity. Postnatal mutant induction is not equivalent to adult gene deletion. Lens-restricted experiments show cataract and nonautonomous anterior-segment changes without detectable UPR.
  modeled_mechanisms:
  - target: Intracellular Collagen IV Retention
    description: Conditional and strain comparisons implicate retention in hemorrhage susceptibility.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:25753534
      reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: intracellular accumulation of mutant collagen in vascular endothelial cells and pericytes was a key triggering factor of ICH
      explanation: Mouse mechanistic comparisons.
      quote_role: PRIMARY_RESULT
  - target: Abnormal Cerebral Vascular Development
    description: Embryonic vascular architecture differs from controls.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:25753534
      reference_title: Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: increased vessel density and tortuosity in Col4a1+/Δex41 hindbrains
      explanation: Embryonic anatomical result.
      quote_role: PRIMARY_RESULT
  - target: Abnormal Ocular Anterior Segment Development
    description: Lens-restricted perturbation causes partial ocular disease.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:28237965
      reference_title: Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: Mice with lens-specific expression of mutant Col4a1 had cataracts
      explanation: Cell-specific expression with ocular readouts.
      quote_role: PRIMARY_RESULT
- name: Col4a1 G498V and G1064D cerebroretinal vascular models
  species: Mouse
  genotype: Heterozygous Col4a1 G498V or G1064D; G498V crossed with Notch3 heterozygous deletion
  publication: PMID:32183562
  description: Models focal arterial smooth-muscle loss and hypermuscularized transitional segments. Retinal preparations permit ex vivo contraction measurements, while intracerebral hemorrhage is measured in brain. Upstream-pressure effects are computational predictions. Notch3 dosage reduction decreases hypermuscularization and hemorrhage without correcting smooth-muscle loss.
  modeled_mechanisms:
  - target: Transitional Vessel Hypermuscularization
    description: Models excess transitional muscular coverage and its genetic suppression.
    relationship: PERTURBS
    fidelity: MODERATE
    evidence:
    - reference: PMID:32183562
      reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: genetic reduction of Notch3 in Col4a1+/G498V mice protected against ICH.
      explanation: Genetic interaction in a defined mutant mouse.
      quote_role: PRIMARY_RESULT
  - target: Arteriolar Smooth Muscle Cell Loss
    description: Anatomically separate arterial degeneration persists after Notch3 reduction.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:32183562
      reference_title: Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: arteriolar SMC loss was unchanged in Col4a1+/G498V, Notch3+/- mice.
      explanation: Null rescue result distinguishes vascular components.
      quote_role: PRIMARY_RESULT
- name: Col4a1 G394V and G1344D age-dependent arterial dysfunction models
  species: Mouse
  genotype: Heterozygous Col4a1 G394V or G1344D; comparisons at 3 and 12 months
  publication: PMID:37963192
  description: Both alleles develop reduced arterial myogenic tone with age, but G394V shows PIP2-dependent TRPM4 impairment whereas G1344D shows impaired SR calcium release. In G1344D, phenylbutyrate from birth preserves function; this is prevention rather than reversal of established adult disease.
  modeled_mechanisms:
  - target: Impaired Cerebral Arterial Myogenic Tone
    description: Models age-dependent arterial contractile dysfunction.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:36693102
      reference_title: Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: is blunted in cerebral arteries from middle-aged (12 mo old) but not young adult (3 mo old) animals
      explanation: G394V pressure-myography comparison. Readout obtained from isolated mutant-mouse vessels or cells.
      quote_role: PRIMARY_RESULT
  - target: Impaired Sarcoplasmic Reticulum Calcium Release
    description: G1344D provides a distinct calcium-release mechanism.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:37963192
      reference_title: Impaired intracellular Ca(2+) signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: the release of SR Ca2+ from RyRs is impaired in the SMCs of Col4a1+/G1344D mice in an age-dependent manner.
      explanation: Ex vivo primary-cell physiology in the mouse model.
      quote_role: PRIMARY_RESULT
- name: Col4a1 multifunction fluorescent-tag and conditional-null mouse
  species: Mouse
  genotype: Dual-color Col4a1 tagged allele with conditional knockout potential
  publication: PMID:40279671
  description: Provides spatial and temporal measurements of postnatal cerebrovascular collagen turnover. Heterozygous deletion was less pathogenic than dominant missense alleles in mice, supporting investigation of allele suppression but not proving a safe human gene-therapy strategy. Human haploinsufficiency cases and species differences remain relevant.
  modeled_mechanisms:
  - target: Abnormal Extracellular Collagen IV Network
    description: Tests matrix turnover and quantitative loss, rather than a misfolded dominant protein.
    relationship: PERTURBS
    fidelity: MODERATE
    evidence:
    - reference: PMID:40279671
      reference_title: A multifunction murine Col4a1 allele reveals potential gene therapy parameters for Gould syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: heterozygous Col4a1 deletion is significantly less pathogenic than dominant Col4a1 missense mutations
      explanation: Relative mouse pathogenicity; not evidence that human COL4A1 loss is harmless.
      quote_role: PRIMARY_RESULT
- name: Adult brain endothelial Col4a1 editing mouse
  species: Mouse
  genotype: AAV-BR1 guide RNA delivery to adult Cas9-transgenic brain endothelium
  publication: PMID:42225261
  description: Adult microvascular Col4a1 depletion produces progressive microbleeds and basement-membrane thinning. Macroscopic hemorrhage and white-matter changes were absent in the reported study. This engineered adult loss model addresses matrix maintenance and does not reproduce germline dominant-negative collagen assembly.
  modeled_mechanisms:
  - target: Cerebral Microvascular Fragility
    description: Tests adult endothelial matrix dependence with a microbleed endpoint.
    relationship: PERTURBS
    fidelity: MODERATE
    evidence:
    - reference: PMID:42225261
      reference_title: A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: Histological examinations revealed haemosiderin deposits corresponding to MRI-detected CMBs, without macroscopic intracerebral haemorrhage or white matter changes.
      explanation: Explicit fidelity limits from the study abstract.
      quote_role: PRIMARY_RESULT
- name: col4a1 crispant and stable delta20 zebrafish
  species: Zebrafish
  genotype: F0 col4a1 CRISPR knockdown and germline-transmissible 20-bp deletion
  publication: PMID:40846110
  description: Crispants show spontaneous hemorrhage and abnormal vascular basement membranes. Stable delta20 larvae show vascular abnormalities and enhanced susceptibility to pharmacologically induced bleeding, whereas adults develop spontaneous brain hemorrhage. Increased mmp9 transcription and partial inhibitor rescue support mechanistic studies. A loss model does not establish dominance or variant-specific human fidelity.
  modeled_mechanisms:
  - target: Increased Matrix Metalloproteinase Activity
    description: Tests the contribution of mmp9 in a whole-animal loss model.
    relationship: PERTURBS
    fidelity: MODERATE
    evidence:
    - reference: PMID:40846110
      reference_title: Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: Pharmacological inhibition of mmp9 was sufficient to ameliorate some cerebrovascular phenotypes.
      explanation: Partial zebrafish rescue; drug efficacy in patients is not established.
      quote_role: PRIMARY_RESULT
- name: col4a1 morphant and multiplex crispant zebrafish
  species: Zebrafish
  genotype: Morpholino knockdown and F0 CRISPR targeting exons 11, 19 and 30; human COL4A1 RNA complementation
  publication: PMID:41248836
  description: Complementary loss models show ventriculomegaly, spontaneous/stress-induced hemorrhage, microphthalmia and lens abnormalities. Wild-type human RNA partially rescues several phenotypes; G755R and G773R rescue is phenotype-dependent and generally impaired. Full text shows partial G773R rescue of one lens-actin readout, so failure is not universal across assays. Developmental complementation is not a therapeutic trial or stand-alone clinical variant-classification rule.
  modeled_mechanisms:
  - target: Abnormal Ocular Anterior Segment Development
    description: Models selected ocular defects and allele-dependent developmental rescue.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:41248836
      reference_title: Zebrafish col4a1 loss-of-function models mirror key neurovascular and ocular features of COL4A1/A2 syndrome and enable human variants assessment in vivo.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: while COL4A1G755R exacerbated the defect observed in col4a1 KD fish
      explanation: Full-text lens-actin assay distinguishes alleles and endpoints.
      quote_role: PRIMARY_RESULT
- name: Col4a1 Raw and Svc renal models
  species: Mouse
  genotype: Heterozygous Col4a1 K950E (Raw) or G1064D (Svc)
  publication: PMID:26839400
  description: Models glomerular/Bowman-capsule defects, hematuria, proteinuria, hypotension and tubular concentrating dysfunction. Chronic renal ER stress and apoptotic markers accompany medullary atrophy. This study did not detect renal cyst formation or tubular basement-membrane defects, and declining filtration did not continue across every age group. Mouse polyuria and diabetes-insipidus findings are not assigned as established human BSVD1 phenotypes.
  modeled_mechanisms:
  - target: Renal Tubular Cell Loss
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: Models a tissue-specific intracellular-stress contribution to renal disease with important human-fidelity limits.
    evidence:
    - *id014
experimental_models:
- name: Human COL4A1/COL4A2 iPSC mural–endothelial co-cultures
  experimental_model_type: CO_CULTURE
  organism:
    preferred_term: Homo sapiens
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:37977146
  cell_source: COL4A1 G755R symptomatic donor and COL4A2 G702D asymptomatic carrier; corrected isogenic clones and independent controls
  description: Neural-crest-derived mural cells are studied during differentiation and after maturation, with endothelial co-culture/conditioned-medium assays. Increased migration, later apoptosis, collagen-matrix abnormalities and stage-dependent MMP dysregulation are partially corrected by doxycycline or marimastat. Brain-endothelial-like cells have epithelial transcriptional features; generic endothelial validation lacks full BBB properties. The COL4A2 donor is an unaffected father, not the symptomatic child from the earlier fibroblast study.
  evidence:
  - reference: PMID:37977146
    reference_title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: we developed a co-culture model of mural and endothelial cells using human induced pluripotent stem cells
    explanation: Model construction in the primary paper.
    quote_role: PRIMARY_RESULT
  modeled_mechanisms:
  - target: Increased Matrix Metalloproteinase Activity
    description: Provides drug perturbation of proteolytic matrix abnormalities.
    relationship: PERTURBS
    fidelity: MODERATE
    evidence:
    - reference: PMID:37977146
      reference_title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: inhibiting MMP activity partially rescues the ECM abnormalities and mural cell phenotypic changes.
      explanation: Partial in-vitro response.
      quote_role: PRIMARY_RESULT
  - target: Endothelial Barrier Dysfunction
    description: Tests mural-cell paracrine injury to endothelial junctions.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:37977146
      reference_title: A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: these mural cell defects exert a detrimental effect on endothelial cell tight junctions through paracrine actions.
      explanation: Culture evidence with endothelial identity limitations.
      quote_role: PRIMARY_RESULT
- name: COL4A1 haploinsufficiency patient fibroblasts
  experimental_model_type: PRIMARY_CELL_CULTURE
  organism:
    preferred_term: Homo sapiens
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:23065703
  cell_source: Primary skin fibroblasts from affected members of two COL4A1 families
  description: Frameshift and splice-site variants are associated with nonsense-mediated transcript decay and reduced COL4A1 protein. These peripheral cells support quantitative deficiency but do not directly reconstruct cerebral vessels or establish all downstream signaling mechanisms.
  evidence:
  - reference: PMID:23065703
    reference_title: Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: a clear reduction of COL4A1 protein expression were demonstrated
    explanation: Patient fibroblast protein-expression result.
    quote_role: PRIMARY_RESULT
  modeled_mechanisms:
  - target: Pathogenic COL4A1 Variation
    description: Distinguishes quantitative loss from mutant-protein retention.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    evidence:
    - reference: PMID:23065703
      reference_title: Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: nonsense-mediated decay (NMD) of the mutant COL4A1 messenger RNAs (mRNAs)
      explanation: Patient-derived transcript evidence.
      quote_role: PRIMARY_RESULT

📚